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Abstract: Background
Maternal depression has a recurring course that can influence offspring outcomes.
There is limited evidence about how to treat maternal depression to improve longer
term maternal outcomes and reduce intergenerational transmission of
psychopathology using task-shifted, low-intensity scalable psychosocial interventions.
We sought to fill this gap, evaluating the effects of a peer-delivered psychosocial
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
depression intervention on maternal depression and child development at 3 years of
age.
Methods
Forty village clusters in Pakistan were randomly allocated to treatment or enhanced
usual care (EUC). Pregnant women aged 18 years or over screening positive for
moderate or severe depression symptoms (Patient Health Questionnaire (PHQ-9)
score 10+) were recruited into the trial (n=570) and a non-depressed cohort was also
enrolled (n=584). Primary outcomes were maternal depression symptoms and
remission (PHQ-9<10) and child socioemotional skills (Strengths and Difficulties
Questionnaire- Total Difficulties (SDQ-TD) at 36-monrha postnatal. Analyses were
intention-to-treat. The trial was registered with ClinicalTrials.gov, number
NCT02658994.
Findings
At 36-months postnatal, complete data were available from 889 mother-child dyads:
206 treatment (72.5%), 216 EUC (75.3%), and 467 prenatally non-depressed (80.0%).
We did not observe significant outcome differences between treatment and EUC arms
of the trial (PHQ-9 total score: Standardized Mean Difference = -0.13, 95% CI -0.33 to
0.07; PHQ-9 remission:  RR= 1.08, 95% CI 0.88 to 1.33; SDQ-TD treatment estimate: -
0·10; 95%CI -1·39, 1·19;).  Approximately 40% of women did not complete their
treatment sessions, and competence levels of peers dropped over time.
Interpretation
Reduced symptom severity and high remission rates were seen across both arms,
possibly masking any  treatment effects.  A multi-year, psychosocial intervention can
be task-shifted via peers but are susceptible to reductions in fidelity and dosage over
time. Early intervention efforts might need to rely on multiple models (e.g. collaborative
care), be of greater intensity, and potentially targeted toward higher risk mothers to
reduce the intergenerational transmission of psychopathology from mothers to
children.
 
This study was funded by a grant from the NIH R01HD075875, NIMH U19MH95687,
and NICHD T32HD007168.
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Abstract  38 
Background 39 
Maternal depression has a recurring course that can influence offspring outcomes. There is limited 40 
evidence about how to treat maternal depression to improve longer term maternal outcomes and 41 
reduce intergenerational transmission of psychopathology using task-shifted, low-intensity scalable 42 
psychosocial interventions. We sought to fill this gap, evaluating the effects of a peer-delivered 43 
psychosocial depression intervention on maternal depression and child development at 3 years of age. 44 
Methods 45 
Forty village clusters in Pakistan were randomly allocated to treatment or enhanced usual care (EUC). 46 
Pregnant women aged 18 years or over screening positive for moderate or severe depression symptoms 47 
(Patient Health Questionnaire (PHQ-9) score 10+) were recruited into the trial (n=570) and a non-48 
depressed cohort was also enrolled (n=584). Primary outcomes were maternal depression symptoms 49 
and remission (PHQ-9<10) and child socioemotional skills (Strengths and Difficulties Questionnaire- Total 50 
Difficulties (SDQ-TD) at 36-monrha postnatal. Analyses were intention-to-treat. The trial was registered 51 
with ClinicalTrials.gov, number NCT02658994. 52 
Findings 53 
At 36-months postnatal, complete data were available from 889 mother-child dyads: 206 treatment 54 
(72.5%), 216 EUC (75.3%), and 467 prenatally non-depressed (80.0%). We did not observe significant 55 
outcome differences between treatment and EUC arms of the trial (PHQ-9 total score: Standardized 56 
Mean Difference = -0.13, 95% CI -0.33 to 0.07; PHQ-9 remission:  RR= 1.08, 95% CI 0.88 to 1.33; SDQ-TD 57 
treatment estimate: -0·10; 95%CI -1·39, 1·19;).  Approximately 40% of women did not complete their 58 
treatment sessions, and competence levels of peers dropped over time. 59 
Interpretation 60 
Reduced symptom severity and high remission rates were seen across both arms, possibly masking any  61 
treatment effects.  A multi-year, psychosocial intervention can be task-shifted via peers but are 62 
susceptible to reductions in fidelity and dosage over time. Early intervention efforts might need to rely 63 
on multiple models (e.g. collaborative care), be of greater intensity, and potentially targeted toward 64 
higher risk mothers to reduce the intergenerational transmission of psychopathology from mothers to 65 
children.  66 
 67 
This study was funded by a grant from the NIH R01HD075875, NIMH U19MH95687, and NICHD 68 
T32HD007168.  69 
  70 
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Research in context 71 
Evidence before this study.  72 
Recent systematic reviews of psychotherapy interventions for depression have highlighted the limited 73 
evidence on long-term effects of psychotherapy on either maternal mental health or child outcomes. 74 
We conducted a search to identify studies designed to evaluate interventions for perinatal depression, 75 
whose intervention either lasted beyond 12 months postnatal (e.g. booster sessions), or whose follow-76 
up was more than 12 after the completion of the intervention, in years 2002-April 2020. We limited our 77 
search to randomized clinical trials or meta-analyses. We did not place restrictions on language or 78 
country. We used Pubmed and Web of Science, with the following search terms: ( (maternal depression) 79 
or (perinatal depression) or (postpartum depression) or (postpartum depression) ) AND ( (treatment) or 80 
(therapy) or (intervention) or (psychotherapy) or (cognitive behavioral therapy) ) AND ( (longer-term) or 81 
(longer) or (booster)). We identified six RCTs specific to perinatal depression with the longer follow-up 82 
period, ranging from 1.5 to 7 years. None utilized an extended duration design (booster sessions) that 83 
continued past 12 months postnatal; two studies included a non-depressed comparison group. Most 84 
common intervention models were Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT).  85 
Evidence generally showed that interventions improved outcomes which then weakened over time so 86 
that, overall, there is limited evidence of intervention effects of perinatal depression interventions that 87 
persist beyond the perinatal period. Of the six studies, two reported some lasting impact. One study of 88 
884 mother-child dyads assessed maternal and child outcomes 7 years after the end of a CBT 89 
intervention and found a 5 point percent lower rates of depression among mothers who received the 90 
intervention, but no significant effects on child outcomes. With this one exception, sample sizes were 91 
small, with studies having fewer than 60 participants per group available at follow-up.  92 
  93 
Added value of this study.  94 
Given the chronic and recurring nature of depression, longer lasting interventions may be necessary to 95 
effectively reduce disease burden and potentially reduce the intergenerational transmission of 96 
psychopathology. This study, in rural Pakistan, is the first large multi-year randomized controlled trial, 97 
focusing on both maternal and child outcomes, where individuals with depression received 98 
psychotherapy beginning prenatally. The extended duration psychosocial intervention evaluated in the 99 
current study did not show evidence of meaningfully reducing depression symptom levels, nor 100 
improving child outcomes, at the 3 years postnatal mark. These findings highlight the challenges of 101 
implementing a peer-delivered psychosocial intervention over a longer period in a low resource 102 
community setting. 103 
Implications of all the available evidence. These findings point to several implementation lessons for 104 
such task-shifted, low-intensity interventions when delivered at scale alongside existing health systems. 105 
These include importance of ensuring high levels of fidelity of the intervention, potentially through use 106 
of technology platforms. It is also important that any intervention be situated within a collaborative care 107 
model that can help detect and respond to women in need of other services to help social determinants 108 
like poverty and domestic violence or pharmacological interventions.       109 
  110 
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Introduction  111 
Global prevalence estimates of depression in the perinatal period range from 4% to over 50%, with the 112 
highest burden in low-resource settings, making depression a public health priority.1   In addition to the 113 
effect of maternal depression on the woman’s functioning, physical health, and risk of suicide, 114 
observational evidence suggests that maternal depression is associated with higher risk of multiple 115 
negative child outcomes, including stunting, socioemotional difficulties, problems with school readiness 116 
and performance, and depressive symptoms over their lifecourse.1,2   Women experiencing perinatal 117 
depression are at much higher risk of subsequent or recurrent episodes of depression and this  chronic 118 
or episodic depression  is most deleterious for numerous maternal and child outcomes.3,4 This risk of 119 
intergenerational transmission of psychopathology is most heavily borne by poorer families and those in 120 
low resource settings with limited access to quality healthcare, thus exacerbating economic and social 121 
inequality.3  122 
Because of the lack of specialists in many LMIC settings, task shifting for maternal depression is 123 
necessitated to bridge the treatment gap.  Evidence-based, task-shifted, targeted maternal depression 124 
or universal psychosocial interventions can be delivered through community health workers as well as 125 
lay peers.5,6  However, most of these interventions are delivered either during pregnancy or in the early 126 
postnatal months, focusing on the acute phase of maternal depression, without tackling issues of 127 
recurrence and chronicity. To our knowledge no depression interventions that begin prenatally are 128 
designed specifically to prevent recurrence after the perinatal period. Hence, the extent to which such 129 
interventions can break the cycle of recurrence of depression beyond the first postnatal year remains 130 
unknown.  131 
 132 
While interventions have demonstrated efficacious reductions in shorter term (i.e. 12 months or less) 133 
maternal depression and improved maternal behaviours,7 we  do not know whether such interventions 134 
can reduce intergenerational transmission to children. Many depression interventions in the perinatal 135 
period include a child development component, opening the possibility that such depression 136 
interventions, including the one studied here, may affect child outcomes through pathways that are 137 
independent of changes in depression symptoms themselves.5 While maternal depression interventions 138 
have been shown to improve key parenting practices,8 evidence of long-term effects on child 139 
socioemotional development is scarce.9 Studies showing improved child outcomes have short post-140 
intervention follow-up periods, typically less than 12 months,10-12 leaving uncertainty about longer 141 
lasting program impacts. The few studies with follow-up longer than one year have reported mixed or 142 
even incongruent effects.4,6,13,14 For example, analysis of the subset of women who were depressed 143 
when beginning the Philani+ program in South Africa, which broadly focused on improving child 144 
outcomes and lasted through 6 months postnatally, showed improved child physical and cognitive 145 
outcomes at 18 months but higher levels of aggression at 5 years of age.6,15 The challenges of differential 146 
attrition in longer-term follow-ups, diminishing sample sizes, and  heterogeneous responses among 147 
particular sub-groups (such as those exposed to poverty or intimate partner violence) make clear 148 
conclusions difficult.2,14     149 
The Thinking Healthy Program, Peer-delivered (THPP), delivered individual and group sessions from 150 
pregnancy to 6 months postnatal and has been evaluated through two randomized controlled trials, one 151 
in Pakistan and one in India.16-18  Although the country specific findings were weak, the pooled analyses 152 
of these trials showed greater recovery from perinatal depression among the intervention group at 6 153 
months postnatal. It also showed that delivering this psychosocial intervention through peers was a 154 
cost-effective, feasible and acceptable approach.16   155 
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We evaluate a 3-year, task-shifted psychosocial peer-delivered intervention for maternal depression, 156 
Thinking Healthy Program, Peer-delivered Plus (THPP+),19 that followed up on the THPP.  The project is 157 
located in rural Pakistan, a low resource context characterized by high levels of maternal depression and 158 
limited access to clinical mental healthcare.20  159 
Although our hypothesis was that the children in the intervention arm will be less high risk (as compared 160 
to those in the control arm), the full impact of the intervention can only be discerned if we know the 161 
level of excess risk remaining- that is, the difference between the reduced level of risk among children 162 
(of prenatally depressed mothers) in the intervention arm and the risk among children whose mothers 163 
were not depressed. If outcomes of these two groups are comparable, we can infer that the 164 
intervention is capable of preventing the intergenerational transmission of risk. To achieve this we 165 
gathered data on women who were not depressed in pregnancy.The resulting pregnancy-birth cohort of 166 
both prenatally depressed (trial participants) and non-depressed women is referred to as the Bachpan 167 
Cohort (Bachpan means Childhood in the local Urdu language). Finally, we examined whether 168 
intervention effects differ by key social contextual factors such as socioeconomic status and intimate 169 
partner violence. 170 
 171 
Methods 172 
Study design and participants 173 
We conducted a stratified cluster-randomized controlled trial in Kallar Syedan, a rural subdistrict of 174 
Rawalpindi, Pakistan. The sub-district is a socioeconomically deprived area with poverty rates around 175 
50%, female literacy of 40-45%, and a high fertility rate (3·8 births per woman).21 It is primarily agrarian 176 
with close knit communities co-residing in large households (average 6·2 people per household). The 177 
sub-district has 11 Union Councils (UC), the smallest administrative unit, each with a population of about 178 
22,000-25,000. Each UC is serviced by a Primary Health Care Facility which houses a physician, midwife, 179 
vaccinator, dispenser, and village-based Lady Health Workers (LHWs).  180 
 181 
This trial maintained the original cluster criterion, randomization sequence and procedures under the 182 
previous trial.16,22  Pregnant women in the 3rd trimester, aged 18+ years and registered with their LHWs, 183 
were eligible. Approximately 95% of the women in the study area were registered with LHWs. All 184 
pregnant women were approached by trained research staff either within the pregnant woman’s 185 
residence or that of their LHW and, if they consented, were assessed. Women who needed immediate 186 
medical or psychiatric inpatient care were excluded from the study. All eligible women were invited to 187 
be screened for depression using the Urdu version of the Patient Health Questionnaire 9 (PHQ-9), which 188 
has been used extensively as a screening tool in the study setting and has an acceptable criterion validity 189 
and reliability for this population.23   Women screening positive (PHQ-9 score > 10) were eligible for 190 
enrolment into the trial and follow-up as part of the Bachpan Cohort.16  One out of every three women 191 
who screened with a < 10 score on PHQ  were enrolled to participate in the Bachpan Cohort only, 192 
resulting in a roughly equal size of prenatally non-depressed and depressed women at the beginning the 193 
cohort.24  194 
 195 
Randomization and masking 196 
The trial was conducted at a sub-district level. Forty village-clusters (population of 2,400 to 3,600) were 197 
the unit of randomization and were geographically separate to minimize contamination risk. The sub-198 
district is administratively subdivided into 11 Union Councils (as explained above and, within each of 199 
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these 11 union councils, we identified an even number of village clusters to ensure that equal numbers 200 
of clusters are randomized into intervention or control condition (ie 1:1 ratio) by an independent 201 
statistician using a computerized randomization sequence. Research teams responsible for identifying, 202 
obtaining consent and recruiting trial participants were blind to the allocation status. The trial PI, site 203 
PIs/coordinators, trial statisticians, and members of the Trial Steering Committee were blinded to the 204 
allocation status until the analysis of the six-month data for the initial THPP trial.25 205 
 206 
The Thinking Healthy Program, Peer-delivered Plus (THPP+) Intervention 207 
The intervention arm received the longer-duration peer-delivered psychosocial intervention (THPP+). It 208 
consisted of 18 group-based “booster” sessions (from 7th to 36th month postnatal). Of these, the first 6 209 
sessions were delivered monthly, then bi-monthly until 36 months. These sessions built on the shorter 210 
duration intervention and were delivered by the same peers. The peers were lay married women who 211 
lived in the same community as that of the depressed women and volunteered their time.  212 
 213 
The key features of this psychosocial intervention, delivered by non-specialists, were peer-support, 214 
behavioural activation, and problem-solving in a culturally sensitive, non-medicalized format, and  215 
developmental activities for children up to the 36th month (See Appendix p.1-3  for the overall structure 216 
of the intervention and peer characteristics.19 A cascaded model of training and supervision was used 217 
which included frequent competence assessments.26 A competency checklist was used for supervision, 218 
including direct observation of the peers, and to provide feedback. Each peer received this assessment 219 
six times over the course of the program. During the feedback meetings, the supervisor discussed 220 
checklist information along with session logs maintained by the peers.  Competence was assessed 221 
through observations and the checklist captured whether content was delivered as intended. Refresher 222 
trainings were done 6 and 18 months after the initial training. The two-day training included re-223 
orientation to the intervention and its principles, as well as training on materials and use of job aids. 224 
 225 
 226 
The intervention group sessions provided a safe environment for women to voice their problems, share 227 
experiences of childcare, and provide support to women. Peer volunteers were trained to use culturally 228 
grounded vignettes that served as tools to deliver health and well-being messages. The sessions aimed 229 
for maternal well-being but also child-care and development by encouraging mother-infant interaction 230 
and play. The intervention provided examples of age-appropriate activities, derived from the 231 
UNICEF/WHO’s Care for Development Package and encouraged demonstration of these activities during 232 
the sessions. While these ‘booster’ group sessions did not focus on specific strategies to address 233 
depression, the peer could still draw on her prior knowledge and skills of specific psychotherapeutic 234 
elements such as behavioural activation when required. Additional details of the intervention are 235 
reported elsewhere.19,26 We defined overall treatment completion as attending 10 (out of 14) sessions 236 
from pregnancy through 6 months postnatal (Phase 1: THPP, individual and group sessions) and 12 (out 237 
of 18) sessions from 7 to 36 months postnatal (Phase 2: THPP+, booster group sessions). 238 
Both intervention and control arms received Enhanced Usual Care (EUC). No treatment was offered to 239 
the prenatally non-depressed women in either of the arms. EUC consisted of informing participants 240 
about their depression status and ways to seek help for it, informing their respective LHWs about 241 
women’s depression status at enrollment, training all the 11 primary care facility-based physicians in the 242 
subdistrict on the mental health Gap Action Programme (mhGAP) treatment guidelines for maternal 243 
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depression,27 and providing depressed participants with a leaflet on how and where to seek appropriate 244 
health care during pregnancy and beyond.   245 
 246 
Procedures  247 
Assessments were conducted 6 times over the course of the study (in pregnancy, and 3, 6, 12, 24, and 248 
36 months postnatal).  As originally specified, the current analysis utilizes mother and child outcome 249 
data at 36 months.22All measures were extensively piloted. Assessments were done at the community 250 
level within households of women by trained interviewers blind to the allocation status, all questions 251 
were interviewer administered. Assessors inter-rater reliability was ensured through classroom-based 252 
training which included role plays, followed by field practice sessions. During these sessions each pair of 253 
assessors assessed up to 10 participants jointly and discussed their coding on each item to establish 254 
inter-rater reliability prior to start of actual data collection.  255 
The project received approval for the IRBs of Human Development Research Foundation (HDRF), Duke 256 
University, and University of North Carolina. The study protocol for the effectiveness trial of THPP+ and 257 
inclusion of prenatally non-depressed pregnant women in the Bachpan Cohort study has been published 258 
previously.16,22     259 
 260 
Outcomes 261 
The primary maternal outcome was depression symptoms assessed using the Patient Health 262 
Questionnaire-9 (PHQ-9) and analyzed as symptom severity (total score) and remission (score < 10).  The 263 
secondary maternal outcomes were disability, assessed using WHO’s Disability Assessment Schedule, 264 
WHO-DAS28, and current major depressive episode based on the Structured Clinical Interview for DSM-IV 265 
(SCID) Disorders.29 Since it provides a clinically salient diagnostic outcome, the SCID was also included to 266 
increase measurement robustness. Process data regarding THPP+ sessions attended, competence scores 267 
of peers, duration of sessions, and peers’ supervision attendance are described elsewhere30 and in the 268 
appendix (p.4-8).  269 
 270 
The primary child outcome was child socioemotional development measured using the Strengths and 271 
Difficulties Questionnaire, Total Difficulties (SDQ-TD) score. The SDQ is a parent-reported measure of 25 272 
child attributes with five subscales: emotional symptoms, conduct problems, hyperactivity, peer 273 
problems, and prosocial behavior.31 The Total Difficulties (TD) score is calculated based on four subscales 274 
(omitting prosocial behaviour) with a score range of 0-40 points. The SDQ is widely used in low- and 275 
middle-income countries and has been translated into Urdu32; in our sample, internal consistency 276 
measured by Cronbach’s alpha was 0.78.  277 
The secondary child outcomes were two developmental domains. Given language differences, two 278 
subscales from the Bayley Scales of Infant and Toddler Development, 3rd edition (BSITD III) were selected 279 
to assess achievement of developmental milestones, the Receptive Language and Fine Motor 280 
subscales.33 The BSITD was administered in the family’s home; scaled scores were calculated using the 281 
child’s chronological age. The BSITD has been widely used and validated internationally.34 282 
An additional outcome of interest, child growth, was analysed using weight- and length-for-age Z-scores.   283 
Additional variables included demographic and psychosocial factors hypothesized to moderate the 284 
effect of the intervention. These included household assets as an indicator of socioeconomic status,35 285 
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maternal education (coded as none vs. any), household composition (nuclear family status), intimate 286 
partner violence (IPV) in the previous 12 months, child gender, maternal age (18-24 vs. 25+), number of 287 
siblings (0 vs. 1+), treatment expectations (very/moderately useful vs. somewhat/not useful), depression 288 
chronicity (<12 weeks vs. ≥12 weeks), and depression severity (PHQ-9 10-14 vs. 15+).23,36    We collected 289 
information on a number of domains that may have been differentially distributed across the treatment 290 
and EUC arms or correlated with loss to follow-up (table 1 and Appendix p.9-14). 291 
Statistical analyses   292 
For mother outcomes, anticipating a sample of 480 prenatally depressed women, we were powered at 293 
90% to detect a remission rate of 65% in the prenatally depressed-intervention versus 45% in prenatally 294 
depressed-control at the two-tailed 5% significance level and assuming a conservative ICC of 0.07 in 295 
intervention arm and 0.05 in control.22 For child outcomes, with this sample size, we were powered at 296 
90% to detect a difference between treatment arms of 3 points on the SDQ-TD at the two-tailed 5% 297 
significance level assuming a standard deviation of 5.2 points and ICC of 0.04-0.08.22  298 
Statistical analyses were done according to the CONSORT guidelines in Stata software version 16.1 299 
(StataCorp, College Station, TX) and SPSS.  All analyses compare the three groups (prenatally depressed 300 
in intervention, prenatally depressed in control, and prenatally non-depressed) across the two arms, 301 
using the 36-month outcomes. We had pre-specified a comparison of outcomes between intervention 302 
and control arms within the prenatally non-depressed women and, in the absence of such an effect, 303 
present results for the overall prenatally non-depressed cohort. 304 
The primary analyses were designed as intention-to-treat.  Data from prenatally depressed and non-305 
depressed participants were analyzed jointly using linear mixed effects models so that all comparisons 306 
of interest could be estimated from the same model. The identity link was used for continuous 307 
outcomes to estimate differences in mean outcomes.  Standardized mean differences (SMDs) and their 308 
95% confidence intervals (CIs) were obtained using the method of Hedges.37 In the primary model, we 309 
included a random intercept for cluster and fixed effects for treatment arm (depressed intervention, 310 
depressed control, non-depressed), union council (11 levels; the stratification variable), and variables 311 
found to be imbalanced by loss to follow-up or at baseline (determined using p<0.10; see Appendix p.9-312 
14). Mixed models assume missing at random conditional on the covariates included in the statistical 313 
model.  Therefore, we include variables predictive of loss to follow-up to account for missing data. 314 
 We used restricted maximum likelihood (REML). The between-within method was used to apply small-315 
sample bias corrections to the intervention effect standard errors in the mixed effects framework.38 316 
These models also generated the intra-cluster correlation (ICC) values. 317 
All binary outcomes were analyzed using generalized estimating equations (GEE).  As with the 318 
continuous outcomes, we include as fixed effects treatment arm and union council, as well as fixed 319 
effects for any variables found to be imbalanced by loss to follow-up or at baseline. In the GEE 320 
framework, we took into account clustering using an exchangeable working correlation matrix. We used 321 
a modified Poisson approach39 and Kauermann-Carroll bias-corrected standard errors to account for the 322 
relatively small number of clusters (i.e. 40).40  When analyzing SCID major depressive episode, we 323 
included SCID at all time points as the outcome in a GEE model with exchangeable working correlation 324 
for village cluster. Additional analyses focus on a priori identified potential moderators of any main 325 
associations with the primary outcomes (described above).  We tested for moderation of the 326 
intervention effect by including these potential moderators in the model as individual interaction terms.   327 




Role of Funding Source 330 
The Funding Source (NIH) had no influence in study design, data collection, data analysis, data 331 
interpretation, or writing of the report.The corresponding authors had full access to all of the data and 332 
the final responsibility to submit for publication. 333 
 334 
Results 335 
From Oct 15, 2014 to Feb 25, 2016, we identified and randomly selected 40 village clusters out of 46 and 336 
randomly assigned 20 village clusters each to intervention (THPP+) and control (EUC) arms. In all we 337 
approached 1910 pregnant women; 287 prenatally depressed women in the control arm and 283 in the 338 
intervention arm completed the baseline questionnaire.  Of the prenatally non-depressed women 339 
approached, 584 were enrolled, yielding comparable numbers of prenatally depressed and prenatally 340 
non-depressed women in each of the 40 village clusters.  341 
Of the 1,154 participants enrolled at baseline, 889 (77.0%) were successfully interviewed at 36 months: 342 
206 (72.5%) intervention, 216 (75.3%) EUC, and 467 (80.0%) prenatally non-depressed (Figure 1). There 343 
was no differential loss to follow up by treatment arm and no differences in adverse events  344 
(Appendix p.9-14).  345 
 346 
At baseline, the mean age of the women in the sample was 26.7 (SD: 4.5) years, with 30.2% of women 347 
being in their first pregnancy. The mean PHQ-9 scores across the treatment arms were similar (14.5 348 
control and 14.9 intervention) with a mean score of 2.8 among prenatally non-depressed women. 349 
Further baseline characteristics are summarized in Table 1. At 36 months, 49.6% of the infants were 350 
girls. 351 
Baseline variables that were imbalanced between intervention and control groups include the life events 352 
checklist score with a higher mean score in the intervention arm. Other variables were found to be 353 
imbalanced but were not included because of collinearity or conceptual overlap (e.g. subjective 354 
religiosity).  Additional baseline demographic variables that were associated with loss to follow-up at 36 355 
months and adjusted for include number of people per room, child’s grandmother living with him/her, 356 
nuclear family status, number of living children and the asset score.  357 
Just over two-thirds of prenatally depressed women in the intervention arm completed the THPP+ 358 
intervention (Appendix p.5). Only 63% of women completed treatment during Phase 2 compared to 359 
nearly 80% treatment completion in Phase 1. The competence levels of the peers declined over the 360 
implementation period, particularly in the period after time point 3 (i.e. at 12 months postnatal) where 361 
we introduced new content for the booster sessions and the frequency of peer supervisions dropped 362 
from monthly to every two months (Appendix p.6-8) show high and low scoring peers and their 363 
competence levels over time 364 
 365 
For all prenatally depressed women, depression scores dropped meaningfully, regardless of their arm 366 
allocation (Figure 2). There were no significant differences in depression outcomes between arms 367 
(THPP+ vs EUC) at 36 months postnatal (Table 2). The adjusted standardized mean difference (SMD) in 368 
depressive symptom severity (PHQ-9) between arms was -0.13 (95% CI -0.33 to 0.07) and the risk ratio 369 
(RR) for depression remission (PHQ-9<10) was 1.00 (95% CI 1.13 to 0.97). Turning to the secondary 370 
outcomes, we observed a relatively larger difference between arms on the secondary outcomes of SCID-371 
based major depressive episode at 36 months (22% control vs 16.5% intervention) (RR=0.67, 95% CI 0.43 372 
10 
 
to 1.05). The intervention effects on disability (SMD=-0.12, 95% CI -0.33 to 0.09) were not statistically 373 
significant.   374 
 375 
The prevalence of major depressive episodes (SCID-based) among the three groups of women (the 376 
prenatally depressed intervention arm, prenatally depressed control arm, and prenatally non-depressed 377 
women) became increasingly similar in the proportion depressed by 36 months postnatal (Figure 2).  378 
The THPP+ intervention arm showed higher convergence with the prenatally non-depressed women at 379 
36 months compared to the control arm, so much so that there was not a statisticaly significant 380 
difference in the probability of being depressed (using SCID) between the intervention arm women (at 381 
16.5%) and the prenatally non-depressed (9.0% of whom were depressed at 36 months, RR 0·74 (0·46 to 382 
1·18).  383 
 384 
We also examined intervention arm differences in depression severity (PHQ-9 scores) at 36 months 385 
postnatal by potential moderators assessed at baseline. There was no strong evidence of meaningful 386 
moderation of the intervention effect by any of these factors (Appendix p.18).  387 
 388 
For the child primary outcome of SDQ-TD, the mean adjusted difference between intervention and 389 
control arms was -0·10; 95% CI -1·39 to 1·19 (Table 2).  There were also no meaningful differences 390 
between the two arms in the secondary outcomes of Receptive Language and Fine Motor scores (from 391 
BSITD) (Table 2),  392 
Similar to maternal depression results, we do not find strong support for the hypothesis that baseline 393 
characteristics moderated treatment effect on the SDQ-TD scores (Appendix p.19).  394 
 395 
 396 
Children of prenatally non-depressed mothers had somewhat better SDQ-TD scores than the 397 
intervention or control arm children (e.g. SDQ-TD=13.7 among the children of the prenatally non-398 
depressed vs. 14.7 in the intervention arm, p-value=0.07, Table 2). In other words, the prenatal 399 
depression episode predicted slightly worse SDQ-TD scores at 36 months of age, independent of the 400 
intervention. Exploratory analyses of the five sub-scales of the SDQ separately showed that this overall 401 
difference was driven by the hyperactivity and conduct problems sub-scales, with negligible differences 402 
by prenatal depression status for the peer problems, emotional problems, and the pro-social scales 403 
(Appendix p.19).   As an example, the adjusted mean difference in the hyperactivity scores between the 404 
non-depressed and the control arm was 0·31 (95% CI -0·62, 0·01, ).  The receptive language, fine motor 405 
and physical growth indicators did not meaningfully differ between the children of prenatally non-406 
depressed and depressed mothers, regardless of intervention arm.  407 
 408 
Discussion 409 
Our study showed that a peer-delivered intervention beginning in pregnancy with booster sessions 410 
through 36-months postnatal did not measurably affect a range of maternal depression symptom and 411 
child developmental outcomes. Though women in theintervention arm did show greater convergence in 412 
depression symptoms with the prenatally non-depressed women at 36 months, relative to women in the 413 
control arm, evidence of a meaningful intervention effect is lacking. We also find only weak evidence 414 
that the prenatal depression episode was itself associated with child socioemotional outcomes and no 415 
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evidence of associations with other developmental outcomes; for the most part, children of prenatally 416 
depressed and prenatally non-depressed mothers had similar outcomes at 36-months of age.  417 
 418 
The overall small effect sizes and lack of statistical significance on maternal outcomes might be 419 
attributable to several factors. First, the intervention was a non-specialist, lay peer delivered 420 
psychosocial intervention. The lay peers were housewives from rural villages, without prior training or 421 
work experience. They were trained and supervised by non-specialists using a cascaded model (with no 422 
direct specialist contact).26 Second, this lay peer delivered approach was used to inform scaling-up of 423 
maternal mental health services through existing health systems and community resources. It is possible 424 
that this non-specialist, low-intensity design, coupled with longer-duration implementation, led to what 425 
Chambers and colleagues refer to as ‘voltage drop’ (the intervention loses some degree of its potency 426 
(or fidelity) when moving from efficacy to effectiveness in the real world) and ‘program drift’ (the 427 
intervention deviates from its manualized or implementation protocols).41 We saw a substantial drop in 428 
women attending the maintenance group sessions delivered every two months beyond the 6th month 429 
postnatal period. This implementation challenge of attendance is reported in other community based 430 
interventions targeting maternal outcomes.42 Women reported that they lost interest in attending these 431 
group sessions or found it demanding on their time. This challenge of poor attendance and how to best 432 
address it came up regularly in peer supervision meetings. In addition to attempts to add more 433 
interesting content to the sessions, we made sure that community health workers reminded women 434 
about the sessions and followed up with those who missed a session. Addressing sustaining participant 435 
interest and limited time is seminal in community-based program success and has been highlighted as 436 
an important challenge in other low resource settings.43 Finally, it is possible that, since the booster 437 
group sessions did not focus on specific strategies to address depression as mentioned earlier, the 438 
intervention arm was not so different from the EUC arm. There were no detectable treatment effects at 439 
the 6 month postnatal wave.16The boosters introduced after the 6 month mark did not change this - we 440 
continue to see no intervention effect at 36 months.  441 
 442 
 443 
Maintaining the competence levels and motivation of the peers over the multi-year long 444 
implementation period was challenging. Perhaps the cascaded model of supervision via non-specialists 445 
led to dropped potency (or fidelity) of sessions. We explored the perceptions of the peers about this 446 
intervention in a nested qualitative study at six months postnatal.26 We did not find any negative 447 
perceptions towards the intervention which might have led to change in motivation or competence 448 
levels.. The reduced frequency of supervision sessions of the peers from every month to every two 449 
months seems to have contributed to the drop in competence levels. This drop in supervisory intensity 450 
has been shown to reduce effectiveness of known approaches.44,45 Another contributing factor to the 451 
drop in competence levels was the addition of new content, beyond the 6th month postnatal period: 452 
both the high and low scoring peers experienced a drop in competence levels when more content was 453 
added. Finding the right balance of content vs capacity of peers, and maintaining fidelity, is an 454 
implementation challenge reported in other programs.46,47  455 
 456 
Finally, we saw a substantial improvement in the control arm (lowered rates and higher recovery from 457 
depression). The control arm recovery rates were higher compared to our previous studies from 2008 458 
and 2020.8,48 This could be attributable to “regression to the mean” or to spillover of the intervention 459 
through the LHWs who regularly interact with LHWs responsible for women residing in control arm sites. 460 
The active control arm received enhanced usual care and some evidence suggests that informing people 461 
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about their illness status improves outcomes,49 which raises important methodological (study design) 462 
issues for trials that are embedded within community settings. Perhaps future trials, using similar active 463 
control arms ought to consider equivalence or non-inferiority trial designs to avoid a nonsignificant 464 
superiority trial being wrongly interpreted, as proof of no difference between the two active 465 
comparisons.50  466 
 467 
We found no clear indications of sub-group differences. This points to the challenge of  intervention 468 
targeting especially given that approximately one-fifth of women did not respond to this treatment, 469 
indicating a need for different interventions. A collaborative care model where non-responders can be 470 
detected earlier and connected to more specialized care may be needed.  471 
 472 
The findings suggesting an association (albeit weak) between prenatal depression and child 473 
socioemotional outcomes at age 3, which is not mitigated by the intervention, mirrors results from our 474 
previous trial with a different sample, designed to examine a similar intervention’s effect on children at 475 
age seven.4 Children’s socioemotional development may be less likely to ‘catch up’ during the resolution 476 
phase of depression within the postnatal period. If confirmed in other studies, differences in 477 
socioemotional, but not other developmental outcomes, may point to specific mechanisms in maternal-478 
child intergenerational transmission of risk.11 479 
 480 
While chronic depression likely has the greatest effect on child development,51 the majority of children 481 
in our study were exposed to varying maternal depression levels, including periods of low or no 482 
depression symptoms over the study period. An association between the prenatal episode and child 483 
socioemotional outcomes at 36 months would be consistent with ‘foetal programming,’52 and is 484 
supported by evidence of linking prenatal depression to a number of child outcomes regardless of 485 
postnatal depression.53 However, inconsistent with foetal programming, another study concluded that a 486 
reduction in maternal depression levels postnatally lead to ‘near normal levels’ of child behavioural 487 
problems.54 488 
 489 
A possible explanation for the lack of intervention effects on child outcomes is that, unlike the trained 490 
specialist delivery in Stein et al’s study, this intervention was delivered by lay peers in a low-income 491 
country.54 As mentioned above, we experienced a ‘voltage drop’ over time in terms of reductions in 492 
both session frequency and attendance, posing significant challenges to sustained implementation.41   493 
Another potential explanation of no group differences in socioemotional outcomes is that the variability 494 
in maternal depression symptoms in the first 3 years could itself be a risk factor. Given that depression is 495 
a chronic, recurring disorder, mothers who were prenatally depressed likely recovered and had a 496 
recurrence. Variation in symptoms over time would be larger among women who entered the study 497 
depressed compared to those non-depressed. It is possible that these children were exposed to 498 
inconsistent or unpredictable parenting, which has been linked with negative behavioral and 499 
socioemotional indicators.55 This hypothesis is supported by results from prior work, showing a 500 
tendency toward worse child anxiety symptoms among children whose mothers relapsed when 501 
compared with those who had chronic depression.4  502 
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Our findings that receptive language, fine motor, and length- and weight-for-age Z scores were not a 503 
function of maternal prenatal depression status or whether she was treated with the intervention are 504 
consistent with our previous study and also with Tomlinson et al who did not observe intervention 505 
effects when looking at the continuous versions of the Bayley Scales and growth outcomes, although 506 
they did report a difference when outcomes were dichotomized.4,6  These results suggest that a 507 
different set of pathways operates for these outcomes relative to socioemotional development. It is 508 
possible that the child’s experience of maternal depression did not, on average, reach severe or chronic 509 
enough levels to affect language and fine motor development and growth. The possibility is consistent 510 
with prior literature that suggests that the most deleterious effects on child outcomes are from severe 511 
and persistent depression levels.51 The presence of other family members, such as the grandmother, 512 
might also buffer any negative impacts of depression on the child. A complementary possibility is that 513 
the effects of maternal depression on these child outcomes are a function of baseline levels of other risk 514 
factors, such as illness, low maternal literacy, intimate partner violence, and others. In samples such as 515 
ours where a large fraction of women carry these risk factors, the effects of depression per se on child 516 
development may be overshadowed. 517 
The study has limitations.  The indicators of child socioemotional outcomes, although measured with 518 
validated and extensively used instruments, were mother-reported and, as such, susceptible to bias.We 519 
addressed this by utilizing only validated instruments used extensively globally. Additionally, if 520 
depression symptoms biased reporting, we would expect this to affect the overall socioemotional 521 
domain. However, in exploratory analyses we found that only specific socioemotional domains were 522 
predicted by prenatal depression; we have no reason to believe that reports of hyperactivity or conduct 523 
problems would be more influenced by depression than reporting of peer or emotional problems.  524 
Overall, our results on the lack of intervention effectiveness for maternal depression and child 525 
development at 36 months suggest three potential scenarios.  First, specific to the socioemotional 526 
domains, the intervention may have been too “light touch” to reverse the effect of prenatal depression 527 
exposure. The peer delivered version of this psychosocial intervention had a weaker effect on maternal 528 
depression than found in a previous study where community health workers were used to deliver the 529 
intervention instead of peer volunteers.16,17   It is likely that women at risk of depression (and their 530 
children) need more than bimonthly group sessions delivered by peers for sustained changes to occur 531 
that will reduce depression’s effect on children. A different model of delivery such as collaborative, or 532 
stepped care, merit consideration, with a number of interventions simultaneously targeting specific 533 
population needs, e.g. domestic violence, poverty alleviation, social services, social health protection 534 
Second, single screening in pregnancy for elevated depression symptoms may not be sufficient to 535 
identify the highest risk women, those who will go on to have the most chronic depression trajectories, 536 
with the worst effects on their children. Targeting women with a history of depression in combination 537 
with other risk factors, such as poverty or IPV, and tailoring the intervention for them, may yield 538 
stronger results. Finally, the program was delivered in a high poverty context. It thus remains possible 539 
that if the entire socio-political environment were to prioritize women and children’s wellbeing and 540 
health, interventions such as ours would have more power to make a difference.     541 
In sum, our findings suggest that prenatal depression may have persistent effects on the child’s 542 
socioemotional skills that are not easily reversed by a psychosocial intervention.  Future preventive and 543 
early intervention efforts might benefit from being higher intensity and target the highest risk mothers.  544 
Importantly, interventions need to be attuned to the social context and ideally implemented as part of a 545 
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Abstract  43 
Background 44 
Maternal depression has a recurring course that can influence offspring outcomes. There is limited 45 
evidence about how to treat maternal depression to improve longer term maternal outcomes and 46 
reduce intergenerational transmission of psychopathology using task-shifted, low-intensity scalable 47 
psychosocial interventions. We sought to fill this gap, evaluating the effects of a peer-delivered 48 
psychosocial depression intervention on maternal depression and child development at 3 years of age. 49 
Methods 50 
Forty village clusters in Pakistan were randomly allocated to treatment or enhanced usual care (EUC). 51 
Pregnant women aged 18 years or over screening positive for moderate or severe depression symptoms 52 
(Patient Health Questionnaire (PHQ-9) score 10+) were recruited into the trial (n=570) and a non-53 
depressed cohort was also enrolled (n=584). Primary outcomes were maternal depression symptoms 54 
and remission (PHQ-9<10) and child socioemotional skills (Strengths and Difficulties Questionnaire- Total 55 
Difficulties (SDQ-TD) at 36-monrha postnatal/. Analyses were intention-to-treat. The trial was registered 56 
with ClinicalTrials.gov, number NCT02658994. 57 
Findings 58 
At 36-months postnatal, complete data were available from 889 mother-child dyads: 206 treatment 59 
(72.5%), 216 EUC (75.3%), and 467 prenatally non-depressed (80.0%). We did not observe significant 60 
outcome differences between treatment and EUC arms of the trial (PHQ-9 total score: Standardized 61 
Meand Difference = -0.13, 95% CI -0.33 to 0.07; PHQ-9 remission:  RR= 1.08, 95% CI 0.88 to 1.33; SDQ-TD 62 
treatment estimate: -0·10; 95%CI -1·39, 1·19;).  Approximately 40% of women did not complete their 63 
treatment sessions, and competence levels of peers dropped over time. 64 
Interpretation 65 
Reduced symptom severity and high remission rates were seen across both arms, possibly masking any  66 
treatment effects.  A multi-year, psychosocial interventions can be task-shifted via peers but are 67 
susceptible to reductions in fidelity and dosage over time. Early intervention efforts might need to rely 68 
on multiple models (e.g. collaborative care), be of greater intensity, and potentially targeted toward 69 
higher risk mothers to reduce the intergenerational transmission of psychopathology from mothers to 70 
children.  71 
 72 
This study was funded by a grant from the NIH R01HD075875, NIMH U19MH95687, and NICHD 73 
T32HD007168.  74 
  75 
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Research in context 76 
Evidence before this study.  77 
Recent systematic reviews of psychotherapy interventions for depression have highlighted the limited 78 
evidence on long-term effects of psychotherapy on either maternal mental health or child outcomes. 79 
We conducted a search to identify studies designed to evaluate interventions for perinatal depression, 80 
whose intervention either lasted beyond 12 months postnatal (e.g. booster sessions), or whose follow-81 
up was more than 12 after the completion of the intervention, in years 2002-April 2020. We limited our 82 
search to randomized clinical trials or meta-analyses. We did not place restrictions on language or 83 
country. We used Pubmed and Web of Science, with the following search terms: ( (maternal depression) 84 
or (perinatal depression) or (postpartum depression) or (postpartum depression) ) AND ( (treatment) or 85 
(therapy) or (intervention) or (psychotherapy) or (cognitive behavioral therapy) ) AND ( (longer-term) or 86 
(longer) or (booster)). We identified six RCTs specific to perinatal depression with the longer follow-up 87 
period, ranging from 1.5 to 7 years. None utilized an extended duration design (booster sessions) that 88 
continued past 12 months postnatal; two studies included a non-depressed comparison group. Most 89 
common intervention models were Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT).  90 
Evidence generally showed that interventions improved outcomes which then weakened over time so 91 
that, overall, there is limited evidence of intervention effects of perinatal depression interventions that 92 
persist beyond the perinatal period. Of the six studies, two reported some lasting impact. One study of 93 
884 mother-child dyads assessed maternal and child outcomes 7 years after the end of a CBT 94 
intervention and found a 5 point percent lower rates of depression among mothers who received the 95 
intervention, but no significant effects on child outcomes. With this one exception, sample sizes were 96 
small, with studies having fewer than 60 participants per group available at follow-up.  97 
  98 
Added value of this study.  99 
Given the chronic and recurring nature of depression, longer lasting interventions may be necessary to 100 
effectively reduce disease burden and potentially reduce the intergenerational transmission of 101 
psychopathology. This study, in rural Pakistan, is the first large multi-year randomized controlled trial, 102 
focusing on both maternal and child outcomes, where individuals with depression received 103 
psychotherapy beginning prenatally. The extended duration psychosocial intervention evaluated in the 104 
current study did not show evidence of meaningfully reducing depression symptom levels, nor 105 
improving child outcomes, at the 3 years postnatal mark. These findings highlight the challenges of 106 
implementing a peer-delivered psychosocial intervention over a longer period in a low resource 107 
community setting. 108 
Implications of all the available evidence. These findings point to several implementation lessons for 109 
such task-shifted, low-intensity interventions when delivered at scale alongside existing health systems. 110 
These include importance of ensuring high levels of fidelity of the intervention, potentially through use 111 
of technology platforms. It is also important that any intervention be situated within a collaborative care 112 
model that can help detect and respond to women in need of other services to help social determinants 113 
like poverty and domestic violence or pharmacological interventions.       114 
  115 
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Introduction  116 
Global prevalence estimates of depression in the perinatal period range from 4% to over 50%, with the 117 
highest burden in low-resource settings, making depression a public health priority.1   In addition to the 118 
effect of maternal depression on the woman’s functioning, physical health, and risk of suicide, 119 
observational evidence suggests that maternal depression is associated with higher risk of multiple 120 
negative child outcomes, including stunting, socioemotional difficulties, problems with school readiness 121 
and performance, and depressive symptoms over their lifecourse.1,2   Women experiencing perinatal 122 
depression are at much higher risk of subsequent or recurrent episodes of depression and this  chronic 123 
or episodic depression  is most deleterious for numerous maternal and child outcomes.3,4 This risk of 124 
intergenerational transmission of psychopathology is most heavily borne by poorer families and those in 125 
low resource settings with limited access to quality healthcare, thus exacerbating economic and social 126 
inequality.3  127 
Because of the lack of specialists in many LMIC settings, task shifting for maternal depression is 128 
necessitated to bridge the treatment gap.  Evidence-based, task-shifted, targeted maternal depression 129 
or universal psychosocial interventions can be delivered through community health workers as well as 130 
lay peers.5,6  However, most of these interventions are delivered either during pregnancy or in the early 131 
postnatal months, focusing on the acute phase of maternal depression, without tackling issues of 132 
recurrence and chronicity. To our knowledge no depression interventions that begin prenatally are 133 
designed specifically to prevent recurrence after the perinatal period. Hence, the extent to which such 134 
interventions can break the cycle of recurrence of depression beyond the first postnatal year remains 135 
unknown.  136 
 137 
While interventions have demonstrated efficacious reductions in shorter term (i.e. 12 months or less) 138 
maternal depression and improved maternal behaviours,7 we  do not know whether such interventions 139 
can reduce intergenerational transmission to children. Many depression interventions in the perinatal 140 
period include a child development component, opening the possibility that such depression 141 
interventions, including the one studied here, may affect child outcomes through pathways that are 142 
independent of changes in depression symptoms themselves.5 While maternal depression interventions 143 
have been shown to improve key parenting practices,8 evidence of long-term effects on child 144 
socioemotional development is scarce.9 Studies showing improved child outcomes have short post-145 
intervention follow-up periods, typically less than 12 months,10-12 leaving uncertainty about longer 146 
lasting program impacts. The few studies with follow-up longer than one year have reported mixed or 147 
even incongruent effects.4,6,13,14 For example, analysis of the subset of women who were depressed 148 
when beginning the Philani+ program in South Africa, which broadly focused on improving child 149 
outcomes and lasted through 6 months postnatally, showed improved child physical and cognitive 150 
outcomes at 18 months but higher levels of aggression at 5 years of age.6,15 The challenges of differential 151 
attrition in longer-term follow-ups, diminishing sample sizes, and  heterogeneous responses among 152 
particular sub-groups (such as those exposed to poverty or intimate partner violence) make clear 153 
conclusions difficult.2,14     154 
The Thinking Healthy Program, Peer-delivered (THPP), delivered individual and group sessions from 155 
pregnancy to 6 months postnatal and has been evaluated through two randomized controlled trials, one 156 
in Pakistan and one in India.16-18  Although the country specific findings were weak, the pooled analyses 157 
of these trials showed greater recovery from perinatal depression among the intervention group at 6 158 
months postnatal. It also showed that delivering this psychosocial intervention through peers was a 159 
cost-effective, feasible and acceptable approach.16   160 
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We evaluate a 3-year, task-shifted psychosocial peer-delivered intervention for maternal depression, 161 
Thinking Healthy Program, Peer-delivered Plus (THPP+),19 that followed up on the THPP.  The project is 162 
located , in rural Pakistan, a low resource context characterized by high levels of maternal depression 163 
and limited access to clinical mental healthcare.20  164 
 165 
Although our hypothesis was that the children in the intervention arm will be less high risk (as compared 166 
to those in the controls arm), the full impact of the intervention can only be discerned if we know the 167 
level of excess risk remaining- that is, the difference between the reduced level of risk among children 168 
(of prenatally depressed mothers) in the intervention arm and the risk among children whose mothers 169 
were not depressed. If outcomes of these two groups are comparable, we can infer that the 170 
intervention is capable of preventing the intergenerational transmission of risk. To achieve this we 171 
gathered data on women who were not depressed in pregnancy.The resulting pregnancy-birth cohort of 172 
both prenatally depressed (trial participants) and non-depressed women is referred to as the Bachpan 173 
Cohort (Bachpan means Childhood in the local Urdu language). Finally, we examined whether 174 
intervention effects differ by key social contextual factors such as socioeconomic status and intimate 175 
partner violence. 176 
 177 
Methods 178 
Study design and participants 179 
We conducted a stratified cluster-randomized controlled trial in Kallar Syedan, a rural subdistrict of 180 
Rawalpindi, Pakistan. The sub-district is a socioeconomically deprived area with poverty rates around 181 
50%, female literacy of 40-45%, and a high fertility rate (3·8 births per woman).21 It is primarily agrarian 182 
with close knit communities co-residing in large households (average 6·2 people per household). The 183 
sub-district has 11 Union Councils (UC), the smallest administrative unit, each with a population of about 184 
22,000-25,000. Each UC is serviced by a Primary Health Care Facility which houses a physician, midwife, 185 
vaccinator, dispenser, and village-based Lady Health Workers (LHWs).  186 
 187 
This trial maintained the original cluster criterion, randomization sequence and procedures under the 188 
previous trial.16,22  Pregnant women in the 3rd trimester, aged 18+ years and registered with their LHWs, 189 
were eligible. Approximately 95% of the women in the study area were registered with LHWs. All 190 
pregnant women were approached by trained research staff either within the pregnant woman’s 191 
residence or that of their LHW and, if they consented, were assessed. Women who needed immediate 192 
medical or psychiatric inpatient care were excluded from the study. All eligible women were invited to 193 
be screened for depression using the Urdu version of the Patient Health Questionnaire 9 (PHQ-9), which 194 
has been used extensively as a screening tool in the study setting and has an acceptable criterion validity 195 
and reliability for this population.23   Women screening positive (PHQ-9 score > 10) were eligible for 196 
enrolment into the trial and follow-up as part of the Bachpan Cohort.16  One out of every three women 197 
who screened with a < 10 score on PHQ  were enrolled to participate in the Bachpan Cohort only, 198 
resulting in a roughly equal size of prenatally non-depressed and depressed women at the beginning the 199 
cohort.24  200 
 201 
Randomization and masking 202 
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The trial was conducted at a sub-district level. Forty village-clusters (population of 2,400 to 3,600) were 203 
the unit of randomization and were geographically separate to minimize contamination risk. The sub-204 
district is administratively subdivided into 11 Union Councils (as explained above and, within each of 205 
these 11 union councils, we identified an even number of village clusters to ensure that equal numbers 206 
of clusters are randomized into intervention or control condition (ie 1:1 ratio) by an independent 207 
statistician using a computerized randomization sequence. Research teams responsible for identifying, 208 
obtaining consent and recruiting trial participants were blind to the allocation status. The trial PI, site 209 
PIs/coordinators, trial statisticians, and members of the Trial Steering Committee were blinded to the 210 
allocation status until the analysis of the six-month data for the initial THPP trial.25 211 
 212 
The Thinking Healthy Program, Peer-delivered Plus (THPP+) Intervention 213 
The intervention arm received the longer-duration peer-delivered psychosocial intervention (THPP+). It 214 
consisted of 18 group-based “booster” sessions (from 7th to 36th month postnatal). Of these, the first 6 215 
sessions were delivered monthly, then bi-monthly until 36 months. These sessions built on the shorter 216 
duration intervention and were delivered by the same peers. The peers were lay married women who 217 
lived in the same community as that of the depressed women and volunteered their time.  218 
 219 
The key features of this psychosocial intervention, delivered by non-specialists, were peer-support, 220 
behavioural activation, and problem-solving in a culturally sensitive, non-medicalized format, and  221 
developmental activities for children up to the 36th month (See Appendix p.1-3  for the overall structure 222 
of the intervention and peer characteristics.19 A cascaded model of training and supervision was used 223 
which included frequent competence assessments.26 A competency checklist was used for supervision, 224 
including direct observation of the peers, and to provide feedback. Each peer received this assessment 225 
six times over the course of the program. During the feedback meetings, the supervisor discussed 226 
checklist information along with session logs maintained by the peers.  Competence was assessed 227 
through observations and the checklist captured whether content was delivered as intended. Refresher 228 
trainings were done 6 and 18 months after the initial training. The two-day training included re-229 
orientation to the intervention and its principles, as well as training on materials and use of job aids. 230 
 231 
 232 
The intervention group sessions provided a safe environment for women to voice their problems, share 233 
experiences of childcare, and provide support to women. Peer volunteers were trained to use culturally 234 
grounded vignettes that served as tools to deliver health and well-being messages. The sessions aimed 235 
for maternal well-being but also child-care and development by encouraging mother-infant interaction 236 
and play. The intervention provided examples of age-appropriate activities, derived from the 237 
UNICEF/WHO’s Care for Development Package and encouraged demonstration of these activities during 238 
the sessions. While these ‘booster’ group sessions did not focus on specific strategies to address 239 
depression, the peer could still draw on her prior knowledge and skills of specific psychotherapeutic 240 
elements such as behavioural activation when required. Additional details of the intervention are 241 
reported elsewhere.19,26 We defined overall treatment completion as attending 10 (out of 14) sessions 242 
from pregnancy through 6 months postnatal (Phase 1: THPP, individual and group sessions) and 12 (out 243 
of 18) sessions from 7 to 36 months postnatal (Phase 2: THPP+, booster group sessions). 244 
Both intervention and control arms received Enhanced Usual Care (EUC). No treatment was offered to 245 
the prenatally non-depressed women in either of the arms. EUC consisted of informing participants 246 
about their depression status and ways to seek help for it, informing their respective LHWs about 247 
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women’s depression status at enrollment, training all the 11 primary care facility-based physicians in the 248 
subdistrict on the mental health Gap Action Programme (mhGAP) treatment guidelines for maternal 249 
depression,27 and providing depressed participants with a leaflet on how and where to seek appropriate 250 
health care during pregnancy and beyond.   251 
 252 
Procedures  253 
Assessments were conducted 6 times over the course of the study (in pregnancy, and 3, 6, 12, 24, and 254 
36 months postnatal).  As originally specified, the current analysis utilizes mother and child outcome 255 
data at 36 months.22All measures were extensively piloted. Assessments were done at the community 256 
level within households of women by trained interviewers blind to the allocation status, all questions 257 
were interviewer administered. Assessors inter-rater reliability was ensured through classroom-based 258 
training which included role plays, followed by field practice sessions. During these sessions each pair of 259 
assessors assessed up to 10 participants jointly and discussed their coding on each item to establish 260 
inter-rater reliability prior to start of actual data collection.  261 
The project received approval for the IRBs of Human Development Research Foundation (HDRF), Duke 262 
University, and University of North Carolina. The study protocol for the effectiveness trial of THPP+ and 263 
inclusion of prenatally non-depressed pregnant women in the Bachpan Cohort study has been published 264 
previously.16,22     265 
 266 
Outcomes 267 
The primary maternal outcome was depression symptoms assessed using the Patient Health 268 
Questionnaire-9 (PHQ-9) and analyzed as symptom severity (total score) and remission (score < 510).  269 
The secondary maternal outcomes were disability, assessed using WHO’s Disability Assessment 270 
Schedule, WHO-DAS28, and current major depressive episode based on the Structured Clinical Interview 271 
for DSM-IV (SCID) Disorders.29 Since it provides a clinically salient diagnostic outcome, the SCID was also 272 
included to increase measurement robustness. Process data regarding THPP+ sessions attended, 273 
competence scores of peers, duration of sessions, and peers’ supervision attendance are described 274 
elsewhere30 and in the appendix (p.4-8).  275 
 276 
The primary child outcome was child socioemotional development measured using the Strengths and 277 
Difficulties Questionnaire, Total Difficulties (SDQ-TD) score. The SDQ is a parent-reported measure of 25 278 
child attributes with five subscales: emotional symptoms, conduct problems, hyperactivity, peer 279 
problems, and prosocial behavior.31 The Total Difficulties (TD) score is calculated based on four subscales 280 
(omitting prosocial behaviour) with a score range of 0-40 points. The SDQ is widely used in low- and 281 
middle-income countries and has been translated into Urdu32; in our sample, internal consistency 282 
measured by Cronbach’s alpha was 0.78.  283 
The secondary child outcomes were two developmental domains. Given language differences, two 284 
subscales from the Bayley Scales of Infant and Toddler Development, 3rd edition (BSITD III) were selected 285 
to assess achievement of developmental milestones, the Receptive Language and Fine Motor 286 
subscales.33 The BSITD was administered in the family’s home; scaled scores were calculated using the 287 
child’s chronological age. The BSITD has been widely used and validated internationally.34 288 
An additional outcome of interest, child growth, was analysed using weight- and length-for-age Z-scores.   289 
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Additional variables included demographic and psychosocial factors hypothesized to moderate the 290 
effect of the intervention. These included household assets as an indicator of socioeconomic status,35 291 
maternal education (coded as none vs. any), household composition (nuclear family status), intimate 292 
partner violence (IPV) in the previous 12 months, child gender, maternal age (18-24 vs. 25+), number of 293 
siblings (0 vs. 1+), treatment expectations (very/moderately useful vs. somewhat/not useful), depression 294 
chronicity (<12 weeks vs. ≥12 weeks), and depression severity (PHQ-9 10-14 vs. 15+).23,36    We collected 295 
information on a number of domains that may have been differentially distributed across the treatment 296 
and EUC arms or correlated with loss to follow-up (table 1 and Appendix p.9-14). 297 
Statistical analyses   298 
For mother outcomes, anticipating a sample of 480 prenatally depressed women, we were powered at 299 
90% to detect a remission rate of 65% in the prenatally depressed-intervention versus 45% in prenatally 300 
depressed-control at the two-tailed 5% significance level and assuming a conservative ICC of 0.07 in 301 
intervention arm and 0.05 in control.22 For child outcomes, with thise sample sample size, we were 302 
powered at 90% to detect a difference between treatment arms of 3 points on the SDQ-TD at the two-303 
tailed 5% significance level assuming a standard deviation of 5.2 points and ICC of 0.04-0.08.22 We were 304 
also well-powered to test for equivalence of SDQ-TD score between children of prenatally depressed 305 
mothers in the treatment arm and children of prenatally non-depressed mothers in the EUC arm, with 306 
equivalence defined as the 95% confidence interval of the mean difference being between -2 and 2 307 
units.  308 
Statistical analyses were done according to the CONSORT guidelines in Stata software version 16.1 309 
(StataCorp, College Station, TX) and SPSS.  All analyses compare the three groups (prenatally depressed 310 
in intervention, prenatally depressed in control, and prenatally non-depressed) across the two arms, 311 
using the 36-month outcomes. We had pre-specified a comparison of outcomes between intervention 312 
and control arms within the prenatally non-depressed women and, in the absence of such an effect, 313 
present results for the overall prenatally non-depressed cohort. 314 
The primary analyses were designed as intention-to-treat.  Data from prenatally depressed and non-315 
depressed participants were analyzed jointly using linear mixed effects models so that all comparisons 316 
of interest could be estimated from the same model. The identity link was used for continuous 317 
outcomes to estimate differences in mean outcomes.  Standardized mean differences (SMDs) and their 318 
95% confidence intervals (CIs) were obtained using the method of Hedges.37 In the primary model, we 319 
included a random intercept for cluster and fixed effects for treatment arm (depressed intervention, 320 
depressed control, non-depressed), union council (11 levels; the stratification variable), and variables 321 
found to be imbalanced by loss to follow-up or at baseline (determined using p<0.10; see Appendix p.9-322 
14). Mixed models assume missing at random conditional on the covariates included in the statistical 323 
model.  Therefore, Wwe include variables predictive of loss to follow-up to account for missing data. 324 
Mixed models assume missing at random, since we include baseline data in the model and adjusting for 325 
variables lost to follow-up will help account for missing data. We used restricted maximum likelihood 326 
(REML). The between-within method was used to apply small-sample bias corrections to the 327 
intervention effect standard errors in the mixed effects framework.38 These models also generated the 328 
intra-cluster correlation (ICC) values. 329 
All binary outcomes were analyzed using generalized estimating equations (GEE).  As with the 330 
continuous outcomes, we include as fixed effects treatment arm and union council, as well as fixed 331 
effects for any variables found to be imbalanced by loss to follow-up or at baseline. In the GEE 332 
framework, we took into account clustering using an exchangeable working correlation matrix. We used 333 
a modified Poisson approach39 and Kauermann-Carroll bias-corrected standard errors to account for the 334 
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relatively small number of clusters (i.e. 40).40  When analyzing SCID major depressive episode, we 335 
included SCID at all time points as the outcome in a GEE model with exchangeable working correlation 336 
for village cluster. Additional analyses focus on a priori identified potential moderators of any main 337 
associations with the primary outcomes (described above).  We tested for moderation of the 338 
intervention effect by including these potential moderators in the model as individual interaction terms.   339 
ClinicalTrials.gov Identifier: NCT02658994 (registered on 21 January 2016). 340 
 341 
Role of Funding Source 342 
The Funding Source (NIH) had no influence in study design, data collection, data analysis, data 343 
interpretation, or writing of the report.The corresponding authors had full access to all of the data and 344 
the final responsibility to submit for publication. 345 
 346 
Results 347 
From Oct 15, 2014 to Feb 25, 2016, we identified and randomly selected 40 village clusters out of 46 and 348 
randomly assigned 20 village clusters each to intervention (THPP+) and control (EUC) arms. In all we 349 
approached 1910 pregnant women; 287 prenatally depressed women in the control arm and 283 in the 350 
intervention arm completed the baseline questionnaire.  Of the prenatally non-depressed women 351 
approached, 584 were enrolled, yielding comparable numbers of prenatally depressed and prenatally 352 
non-depressed women in each of the 40 village clusters.  353 
Of the 1,154 participants enrolled at baseline, 889 (77.0%) were successfully interviewed at 36 months: 354 
206 (72.5%) intervention, 216 (75.3%) EUC, and 467 (80.0%) prenatally non-depressed (Figure 1). There 355 
was no differential loss to follow up by treatment arm and no differences in adverse events  356 
(Appendix p.9-14).  357 
 358 
At baseline, the mean age of the women in the sample was 26.7 (SD: 4.5) years, with 30.2% of women 359 
being in their first pregnancy. The mean PHQ-9 scores across the treatment arms were similar (14.5 360 
control and 14.9 intervention) with a mean score of 2.8 among prenatally non-depressed women. 361 
Further baseline characteristics are summarized in Table 1. At 36 months, 49.6% of the infants were 362 
girls. 363 
Baseline variables that were imbalanced between intervention and control groups include the life events 364 
checklist score with a higher mean score in the intervention arm. Other variables were found to be 365 
imbalanced but were not included because of collinearity or conceptual overlap (e.g. subjective 366 
religiosity).  Additional baseline demographic variables that were associated with loss to follow-up at 36 367 
months and adjusted for include number of people per room, child’s grandmother living with him/her, 368 
nuclear family status, number of living children and the asset score.  369 
Just over two-thirds of prenatally depressed women in the intervention arm completed the THPP+ 370 
intervention (Appendix p.5). Only 63% of women completed treatment during Phase 2 compared to 371 
nearly 80% treatment completion in Phase 1. The competence levels of the peers declined over the 372 
implementation period, particularly in the period after time point 3 (i.e. at 12 months postnatal) where 373 
we introduced new content for the booster sessions and the frequency of peer supervisions dropped 374 
from monthly to every two months (Aappendix p.6-8) show high and low scoring peers and their 375 




For all prenatally depressed women, depression scores dropped meaningfully, regardless of their arm 378 
allocation (Figure 2). There were no significant differences in depression outcomes between arms 379 
(THPP+ vs EUC) at 36 months postnatal (Table 2). The adjusted standardized mean difference (SMD) in 380 
depressive symptom severity (PHQ-9) between arms was -0.13 (95% CI -0.33 to 0.07) and the risk ratio 381 
(RR) for depression remission (PHQ-9<10) was 1.00 (95% CI 1.13 to 0.97). Turning to the secondary 382 
outcomes, we observed a relatively larger difference between arms on the secondary outcomes of SCID-383 
based major depressive episode at 36 months (22% control vs 16.5% intervention) (RR=0.67, 95% CI 0.43 384 
to 1.05). The intervention effects on disability (SMD=-0.12, 95% CI -0.33 to 0.09) were not statistically 385 
significant.   386 
 387 
The prevalence of SCID-based major depressive episodes (SCID-based) among the three groups of 388 
women (: the prenatally depressed intervention arm, prenatally depressed control arm, and prenatally 389 
non-depressed women) became increasingly similar in the proportion depressed by 36 months 390 
postnatal (Ffigure 2).  The THPP+ intervention arm showed higher convergence with the prenatally non-391 
depressed women at 36 months compared to the control arm, so much so that there was not a 392 
statisticaly significant difference in the probability of being depressed (using SCID) between the 393 
intervention arm women (at 16.5%) and the prenatally non-depressed (9.0% of whom were depressed 394 
at 36 months, RR 0·74 (0·46 to 1·18).  395 
 396 
We also examined intervention arm differences in depression severity (PHQ-9 scores) at 36 months 397 
postnatal by potential moderators assessed at baseline. There was no strong evidence of meaningful 398 
moderation of the intervention effect by any of these factors (Appendix p.18).  399 
 400 
For the child primary outcome of SDQ-TD, the mean adjusted difference between intervention and 401 
control arms was -0·10; 95% CI -1·39 to 1·19 (Table 2).  There were also no meaningful differences 402 
between the two arms in the secondary outcomes of Receptive Language and Fine Motor scores (from 403 
BSITD) (Table 2),  404 
Similar to maternal depression results, we do not find strong support for the hypothesis that baseline 405 
characteristics moderated treatment effect on the SDQ-TD scores (Appendix p.19).  406 
 407 
 408 
Children of prenatally non-depressed mothers had somewhat better SDQ-TD scores than the 409 
intervention or control arm children (e.g. SDQ-TD=13.7 among the children of the prenatally non-410 
depressed vs. 14.7 in the intervention arm, p-value=0.07, Table 2). In other words, the prenatal 411 
depression episode predicted slightly worse SDQ-TD scores at 36 months of age, independent of the 412 
intervention. Exploratory analyses of the five sub-scales of the SDQ separately showed that this overall 413 
difference was driven by the hyperactivity and conduct problems sub-scales, with negligible differences 414 
by prenatal depression status for the peer problems, emotional problems, and the pro-social scales 415 
(Appendix p.19).   As an example, the adjusted mean difference in the hyperactivity scores between the 416 
non-depressed and the control arm was 0·31 (95% CI -0·62, 0·01, ).  The receptive language, fine motor 417 
and physical growth indicators did not meaningfully differ between the children of prenatally non-418 





Our study showed that a peer-delivered intervention beginning in pregnancy with booster sessions 422 
through 36-months postnatal did not measurably affect a range of maternal depression symptom and 423 
child developmental outcomes. Though women in the treatment intervention arm did show greater 424 
convergence in depression symptoms with the prenatally non-depressed women at 36 months, relative 425 
to women in the control arm, evidence of a meaningful intervention effect is lacking. We also find only 426 
weak evidence that the prenatal depression episode was itself associated with child socioemotional 427 
outcomes and no evidence of associations with other developmental outcomes; for the most part, 428 
children of prenatally depressed and prenatally non-depressed mothers had similar outcomes at 36-429 
months of age.  430 
 431 
The overall small effect sizes and lack of statistical significance on maternal outcomes might be 432 
attributable to several factors. First, the intervention was a non-specialist, lay peer delivered 433 
psychosocial intervention. The lay peers were housewives from rural villages, without prior training or 434 
work experience. They were trained and supervised by non-specialists using a cascaded model (with no 435 
direct specialist contact). 26 Second, this lay peer delivered approach was used to inform scaling-up of 436 
maternal mental health services through existing health systems and community resources. It is possible 437 
that this non-specialist, low-intensity design, coupled with longer-duration implementation, led to what 438 
Chambers and colleagues refer to as ‘voltage drop’ (the intervention loses some degree of its potency 439 
(or fidelity) when moving from efficacy to effectiveness in the real world) and ‘program drift’ (the 440 
intervention deviates from its manualized or implementation protocols).41 We saw a substantial drop in 441 
women attending the maintenance group sessions delivered every two months beyond the 6th month 442 
postnatal period. This implementation challenge of attendance is reported in other community based 443 
interventions targeting maternal outcomes.42 Women reported that the womeny lost interest in 444 
attending these group sessions or found it demanding on their time. This challenge of poor attendance 445 
and how to best address it came up regularly in peer supervision meetings. In addition to attempts to 446 
add more interesting content to the sessions, we made sure that community health workers reminded 447 
women about the sessions and followed up with those who missed a session. Addressing sustaining 448 
participant interest and limited time is seminal in community-based program success and has been 449 
highlighted as an important challenge in other low resource settings.43 Finally, it is possible that, since 450 
the booster group sessions did not focus on specific strategies to address depression as mentioned 451 
earlier, the intervention arm was not so different from the EUC arm. There were no detectable 452 
treatment effects at the 6 month postnatal wave.16The boosters introduced after the 6 months mark did 453 
not change this - we continue to see no intervention effect at 36 months.  454 
 455 
 456 
Maintaining the competence levels and motivation of the peers over the multi-year long 457 
implementation period was challenging. Perhaps the cascaded model of supervision via non-specialists 458 
led to dropped potency (or fidelity) of sessions. We explored the perceptions of the peers about this 459 
intervention in a nested qualitative study at six months postnatal.26 We did not find any negative 460 
perceptions towards the intervention which might have led to change in motivation or competence 461 
levels.. The reduced frequency of supervision sessions of the peers from every month to every two 462 
months seems to have contributed to the drop in competence levels. This drop in supervisory intensity 463 
has been shown to reduce effectiveness of known approaches.44,45 Another contributing factor to the 464 
drop in competence levels was the addition of new content, beyond the 6th month postnatal period: 465 
both the high and low scoring peers experienced a drop in competence levels when more content was 466 
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added. Finding the right balance of content vs capacity of peers, and maintaining fidelity, is an 467 
implementation challenge reported in other programs.46,47  468 
 469 
Finally, we saw a substantial improvement in the control arm (lowered rates and higher recovery from 470 
depression). The control arm recovery rates were higher compared to our previous studies from 2008 471 
and 2020.8,48 This could be attributable to “regression to the mean” or to spillover of the intervention 472 
through the LHWs who regularly interact with LHWs responsible for women residing in control arm sites. 473 
The active control arm received enhanced usual care and some evidence suggests that informing people 474 
about their illness status improves outcomes,49 which raises important methodological (study design) 475 
issues for trials that are embedded within community settings. Perhaps future trials, using similar active 476 
control arms ought to consider equivalence or non-inferiority trial designs to avoid a nonsignificant 477 
superiority trial being wrongly interpreted, as proof of no difference between the two active 478 
comparisons.50  479 
 480 
We found no clear indications of sub-group differences. This points to the challenge of  intervention 481 
targeting especially given that approximately one-fifth of women did not respond to this treatment, 482 
indicating a need for different interventions. A collaborative care model where non-responders can be 483 
detected earlier and connected to more specialized care may be needed.  484 
 485 
The findings suggesting an association (albeit weak) between prenatal depression and child 486 
socioemotional outcomes at age 3, which is not mitigated by the intervention, mirrors results from our 487 
previous trial with a different sample, designed to examine a similar intervention’s effect on children at 488 
age seven.4 Children’s socioemotional development may be less likely to ‘catch up’ during the resolution 489 
phase of depression within the postnatal period. If confirmed in other studies, differences in 490 
socioemotional, but not other developmental outcomes, may point to specific mechanisms in maternal-491 
child intergenerational transmission of risk.11 492 
 493 
While chronic depression likely has the greatest effect on child development,51 the majority of children 494 
in our study were exposed to varying maternal depression levels, including periods of low or no 495 
depression symptoms over the study period. An association between the prenatal episode and child 496 
socioemotional outcomes at 36 months would be consistent with ‘foetal programming,’52 and is 497 
supported by evidence of linking prenatal depression to a number of child outcomes regardless of 498 
postnatal depression.53 However, inconsistent with foetal programming, another study concluded that a 499 
reduction in maternal depression levels postnatally lead to ‘near normal levels’ of child behavioural 500 
problems.54 501 
 502 
A possible explanation for the lack of intervention effects on child outcomes is that, unlike the trained 503 
specialist delivery in Stein et al’s study, this intervention was delivered by lay peers in a low-income 504 
country.54 As mentioned above, we experienced a ‘voltage drop’ over time in terms of reductions in 505 
both session frequency and attendance, posing significant challenges to sustained implementation.41   506 
Another potential explanation of no group differences in socioemotional outcomes is that the variability 507 
in maternal depression symptoms in the first 3 years could itself be a risk factor. Given that depression is 508 
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a chronic, recurring disorder, mothers who were prenatally depressed likely recovered and had a 509 
recurrence. Variation in symptoms over time would be larger among women who entered the study 510 
depressed compared to those non-depressed. It is possible that these children were exposed to 511 
inconsistent or unpredictable parenting, which has been linked with negative behavioral and 512 
socioemotional indicators.55 This hypothesis is supported by results from prior work, showing a 513 
tendency toward worse child anxiety symptoms among children whose mothers relapsed when 514 
compared with those who had chronic depression.4  515 
Our findings that receptive language, fine motor, and length- and weight-for-age Z scores were not a 516 
function of maternal prenatal depression status or whether she was treated with the intervention are 517 
consistent with our previous study and also with Tomlinson et al who did not observe intervention 518 
effects when looking at the continuous versions of the Bayley Scales and growth outcomes, although 519 
they did report a difference when outcomes were dichotomized.4,6  These results suggest that a 520 
different set of pathways operates for these outcomes relative to socioemotional development. It is 521 
possible that the child’s experience of maternal depression did not, on average, reach severe or chronic 522 
enough levels to affect language and fine motor development and growth. The possibility is consistent 523 
with prior literature that suggests that the most deleterious effects on child outcomes are from severe 524 
and persistent depression levels.51 The presence of other family members, such as the grandmother, 525 
might also buffer any negative impacts of depression on the child. A complementary possibility is that 526 
the effects of maternal depression on these child outcomes are a function of baseline levels of other risk 527 
factors, such as illness, low maternal literacy, intimate partner violence, and others. In samples such as 528 
ours where a large fraction of women carry these risk factors, the effects of depression per se on child 529 
development may be overshadowed. 530 
The study has limitations.  The indicators of child socioemotional outcomes, although measured with 531 
validated and extensively used instruments, were mother-reported and, as such, susceptible to bias.We 532 
addressed this by utilizing only validated instruments used extensively globally. Additionally, if 533 
depression symptoms biased reporting, we would expect this to affect the overall socioemotional 534 
domain. However, in exploratory analyses we found that only specific socioemotional domains were 535 
predicted by prenatal depression; we have no reason to believe that reports of hyperactivity or conduct 536 
problems would be more influenced by depression than reporting of peer or emotional problems.  537 
Overall, our results on the lack of intervention effectiveness for maternal depression and child 538 
development at 36 months suggest three potential scenarios.  First, specific to the socioemotional 539 
domains, the intervention may have been too “light touch” to reverse the effect of prenatal depression 540 
exposure. The peer delivered version of this psychosocial intervention had a weaker effect on maternal 541 
depression than found in a previous study where community health workers were used to deliver the 542 
intervention instead of peer volunteers.16,17   It is likely that women at risk of depression (and their 543 
children) need more than bimonthly group sessions delivered by peers for sustained changes to occur 544 
that will reduce depression’s effect on children. A different model of delivery such as collaborative, or 545 
stepped care, merit consideration, with a number of interventions simultaneously targeting specific 546 
population needs, e.g. domestic violence, poverty alleviation, social services, social health protection 547 
Second, single screening in pregnancy for elevated depression symptoms may not be sufficient to 548 
identify the highest risk women, those who will go on to have the most chronic depression trajectories, 549 
with the worst effects on their children. Targeting women with a history of depression in combination 550 
with other risk factors, such as poverty or IPV, and tailoring the intervention for them, may yield 551 
stronger results. Finally, the program was delivered in a high poverty context. It thus remains possible 552 
that if the entire socio-political environment were to prioritize women and children’s wellbeing and 553 
health, interventions such as ours would have more power to make a difference.     554 
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In sum, our findings suggest that prenatal depression may have persistent effects on the child’s 555 
socioemotional skills that are not easily reversed by a psychosocial intervention.  Future preventive and 556 
early intervention efforts might benefit from being higher intensity and target the highest risk mothers.  557 
Importantly, interventions need to be attuned to the social context and ideally implemented as part of a 558 
suite of health promoting policies that address social determinants of maternal and child health.   559 
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Table 1: Baseline characteristics of women in study population (n=1154) 
 
Characteristics 
Control Arm  Intervention Arm 
Prenatally Non-depressed 
(EUC) (THPP/THPP+) 
(N = 287) (N = 283) (N = 584) 
N (%) or mean (SD) N (%) or mean (SD) N (%) or mean (SD) 
Mother’s age  27·29 (4·97) 26·80 (4·60) 26·37 (4·26) 
18-24 83 (28·9%) 88 (31·1%) 203 (34·8%) 
25+ 204 (71·1%) 195 (68·9%) 381 (65·2%) 
Mother's Education (in years)    
      None (0) 55 (19·2%) 52 (18·4%) 63 (10·8%) 
      Primary (1-5) 71 (24·7%) 68 (24·0%) 87 (14·9%) 
      Middle/Secondary (6-12) 134 (46·7%) 145 (51·2%) 338 (57·9%) 
      Tertiary (13+) 27 (9·4%) 18 (6·4%) 96 (16·4%) 
Mother's Education (in years)      
      None (0) 55 (19·2%) 52 (18·4%) 63 (10·8%) 
      Any (1+) 232 (80·8%) 231 (81·6%) 521 (89·2%) 
Nuclear Family 49 (17·1%) 50 (17·7%) 59 (10·1%) 
Total Number of Children in the Household 2·97 (2·67) 3·09 (2·71) 2·51 (2·63) 
Number of Children     
      First pregnancy 72 (25·1%) 65 (23·0%) 212 (36·3%) 
      1 to 3 183 (63·8%) 180 (63·6%) 336 (57·5%) 
  4+  32 (11·1%) 38 (13·4%) 36 (6·2%) 
SCID (MDE) 210 (73·2%) 218 (77·0%) 14 (2·4%) 
PHQ-9 Total Score 14·48 (3·58) 14·89 (3·72) 2·80 (2·46) 
Severity (PHQ-9 score)     
      10-14 167 (58·2%) 145 (51·2%) 584 (100·0%) 
      ≥15 120 (41·8%) 138 (48·8%) 0 (0·0%) 
MSPSS Total Score 3·95 (1·33) 3·92 (1·41) 4·97 (1·01) 
WHO-DAS Total Score 16·11 (9·12) 16·71 (8·52) 5·61 (6·46) 
Duration of Depression (Chronicity)     
  <12 weeks  38 (13·2%) 35 (12·4%)   
      ≥12 weeks 155 (54·0%)  171 (60·4%) N/A 
     missing 94 (32·8%) 77 (27·2%)   
SES (Assets)    
      Lowest Quintile 74 (25·8%) 85 (30·0%) 71 (12·2%) 
      Lower Middle Quintile 67 (23·3%) 71 (25·1%) 93 (15·9%) 
      Middle Quintile 55 (19·2%) 50 (17·7%) 126 (21·6%) 
      Upper Middle Quintile 47 (16·4%) 39 (13·8%) 145 (24·8%) 
      Upper Quintile 44 (15·3%) 38 (13·4%) 149 (25·5%) 
SES (Assets index)     
Bottom 1/3rd 109 (38·0%) 119 (42·0%) 113 (19·3%) 
Top 2/3rds 178 (62·0%) 164 (58·0%) 471 (80·7%) 
Number of people per room 2·47 (1·87) 2·79 (2·03) 2·22 (1·79) 
Life Events Checklist Score 4·10 (2·33) 4·70 (2·44) 2·90 (2·16) 
Any IPV (last 12 months)  165 (59·1%) 178 (65·4%) 179 (33·0%) 
Table
Treatment Expectations     
       None/somewhat   76 (26·5%) 70 (24·7%) N/A 







Table 2. Primary and Secondary maternal and child trial outcomes at 36 months postnatal 
 
 
Control Arm (EUC) 
(N=216) 
mean (SD) or N (%) 
Intervention Arm 
(N=206) 




mean (SD) or 
N (%) 
Adjusted Standardized Mean 
Difference (SMD)  
or adjusted RR (95% CI) for 
Intervention vs Control arm 
ICC* 
PRIMARY OUTCOMES      
Maternal PHQ-9 score 6·48 (6·25) 5·84 (5·80) 3.44 (4.53) SMD= -0·13 (-0·33, 0·07) 0·009 
Remission: PHQ-9 < 10 score 54 (75.0%) 51 (75.2%) 61 (86.9%) 1.00 (0.88, 1.13) <0.001 
 Child SDQ-Total Difficulties  14·72 (6·13) 14·73 (6·04) 13·69 (6·34) -0·10 (-1·39, 1·19) 0.020 
SECONDARY OUTCOMES      
Maternal Major Depressive episode 
(SCID) 
48 (22·2%) 34 (16·5%) 42 (9.0%) RR= 0·67 (0·43, 1·05) <0·001 
Maternal Disability (WHO-DAS) 6·78 (9·44) 5·87 (8·06) 3.34 (6.19) SMD= -0·12 (-0·33,0·09) 0·018 
Child Bayley Scaled Receptive Score  9·98 (2·60) 10·42 (2·81) 10·41 (2·79) 0·38 (-0·19, 0·96) 0.027 
Child Bayley Scaled Fine Motor Score   11·38 (4·12) 11·42 (4·05) 11·31 (3·99) 0·03 (-0·83, 0·90) 0.039 
PHQ-9: Patient Healthy Questionnaire; SDQ: Strength and Difficulties Questionnaire; SCID: Structured Clinical Interview for 
DSM-IV; WHO-DAS: World Health Organization – Disability Assessment Schedule; SD: Standard Deviation; RR: Risk Ratio;  
ICC: Intra-cluster correlation. * ICC comes from the mixed models; for the binary outcomes the ICCs are based on mixed-effects 

















Lost to follow-up:  moved (n=9), temporarily 
absent (n=37),  loss of child (n=26), child illness 
(n=3). 
Refusals (n=1).
Lost to follow-up:  moved (n=7), temporarily 
absent (n=21),  loss of child (n=25), child illness 
(n=4).
Refusals (n=3).
Lost to follow-up:  moved (n=6), temporarily 
absent (n=78),  loss of child (n=42), child illness 
(n=4).
Refusals (n=1).
Lost to follow-up:  moved (n=2), temporarily 
absent (n=16),  loss of child (n=1). 
Refusals (n=1).
Lost to follow-up:  moved (n=2), temporarily 
absent (n=11). 
Refusals (n=1).
Lost to follow-up:  moved (n=3), temporarily 
absent (n=51), loss of child (n=2).
Refusals (n=2).
Lost to follow-up:  temporarily absent (n=10),  
loss of child (n=3). 
Refusals (n=3).
Lost to follow-up:  moved (n=3), temporarily 
absent (n=9), mother was ill (n=1), loss of child 
(n=2), mother died (n=1). Refusals (n=2).
Lost to follow-up:  moved (n=2), temporarily 
absent (n=22), mother was ill (n=1), loss of child 
(n=2), mother died (n=1), child hernia (n=1), 
child disabled (n=1) 
Refusals (n=3).
Lost to follow-up:  moved (n=2), temporarily 
absent (n=12),  loss of child (n=2),  child illness 
(n=1).
Refusals (n=2).
Lost to follow-up:  moved (n=4), temporarily 
absent (n=15),  loss of child (n=1). 
Lost to follow-up:  moved (n=5), temporarily 
absent (n=23),  child illness (n=1). 
Refusals (n=4).
Lost to follow-up:  moved (n=8), temporarily 
absent (n=4), child illness (n=1), loss of child 
(n=2), child developmentally delayed (n=1), mom 
death (n=1). 
Refusals (n=3).
Lost to follow-up:  moved (n=9), temporarily 
absent (n=10), child illness (n=2), loss of child 
(n=1), child developmentally delayed (n=1).
Refusals (n=1).
Lost to follow-up:  moved (n=16), temporarily 






























































Mean cluster size 14.4 (SD 0.7) Mean cluster size 14.2 (SD 0.4) Mean cluster size 14.6 (SD 1.4)
Mean cluster size 10.6 (SD 2.5)
Mean cluster size 11.4 (SD 2.0)
Mean cluster size 11.4 (SD 1.7)
Mean cluster size 11.0 (SD 1.5)
Mean cluster size 10.8 (SD 1.8)
Mean cluster size 11.2 (SD 1.2)
Mean cluster size 11.5 (SD 1.6)
Mean cluster size 11.2 (SD 1.5)
Mean cluster size 10.5 (SD 1.6)
Mean cluster size 10.3 (SD 1.6)
Mean cluster size 11.3 (SD 2.2)
Mean cluster size 11.8 (SD 1.9)
Mean cluster size 12.2 (SD 1.8)
Mean cluster size 11.8 (SD 2.0)
Mean cluster size 11.7 (SD 1.8)
EUC control group:
287 women with data
THPP intervention group:
283 women with data
Prenatally non-depressed group:
584 women with data
EUC control group:
221 dyads with follow-up data
THPP intervention group:
223 dyads with follow-up data
Prenatally non-depressed group:
451 dyads with follow-up data
EUC control group:
228 dyads with follow-up data
THPP intervention group:
230 dyads with follow-up data
Prenatally non-depressed group:
471 dyads with follow-up data
EUC control group:
228 dyads with follow-up data
THPP+ intervention group:
223 dyads with follow-up data
Prenatally non-depressed group:
489 dyads with follow-up data
EUC control group:
220 dyads with follow-up data
THPP+ intervention group:
210 dyads with follow-up data
Prenatally non-depressed group:
473 dyads with follow-up data
EUC control group:
216 dyads with follow-up data
THPP+ intervention group:
206 dyads with follow-up data
Prenatally non-depressed group:
467 dyads with follow-up data
Mean cluster size 29.0 (SD 7.7)
1,159 prenatally non-depressed 
women
Refusals (n=1). Refusals (n=1).
Prenatally non-depressed women not invited to 








Mean cluster size 14.2 (SD 0.4)
284 women assigned to THPP
intervention group
Mean cluster size 14.4 (SD 0.8)
288 assigned to enhanced usual care
(EUC) control  group
46 village clusters assessed for eligibility
Excluded due to 
ineligibility = 154 
- In 1st or 2nd trimester 
of pregnancy = 110
- Age <18 years =8
- Does not intend to 
remain in area for 
duration of study=11
- Does not speak Urdu, 
Punjabi, Potohari or 
English=22
Needed imminent care= 3
Refusals = 25
6 village clusters randomly selected for exclusion as 
per sample size calculations
40 village clusters included (1910 potential participants) 





































Figure 2 title 







*Abbreviations: SCID – Structured Clinical Interview for Depression; MDE – Major Depressive Episode. 
**Predicted prevalences come from a longitudinal GEE model with SCID at all time points as the outcome.  Time point, intervention arm 
(depressed in intervention, depressed in  control, and non-depressed), and the interaction between these two variables are included in the 
model.  In addition, the model is adjusted for the variables imbalanced at baseline or differential by missingness at any time point (see footnote to 
Table 3).  An exchangeable working correlation matrix is used to take into account clustering by village cluster.  Marginal predicted prevalences 
are computed from this model—at the average of continuous adjustors and the population percentages of categorical adjustors—and these are 
graphed by intervention arm. 
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Abstract
Background: The negative effects of perinatal depression on the mother and child start early and persist
throughout the lifecourse (Lancet 369(9556):145–57, 2007; Am J Psychiatry 159(1):43-7, 2002; Arch Dis Child 77(2):
99–101, 1997; J Pak Med Assoc 60(4):329; J Psychosoma Res 49(3):207–16, 2000; Clin Child Fam Psychol Rev 14(1):
1–27, 2011). Given that 10–35% of children worldwide are exposed to perinatal depression in their first year of life
(Int Rev Psychiatry 8(1):37–54, 1996), mitigating this intergenerational risk is a global public health priority (Perspect
Public Health 129(5):221–7, 2009; Trop Med Int Health 13(4):579–83, 2008; Br Med Bull 101(1):57–79, 2012). However,
it is not clear whether intervention with depressed women can have long-term benefits for the mother and/or her
child. We describe a study of the effectiveness of a peer-delivered depression intervention delivered through 36 postnatal
months, the Thinking Healthy Program Peer-delivered PLUS (THPP+) for women and their children in rural Pakistan.
Methods/design: The THPP+ study aims are: (1) to evaluate the effects of an extended 36-month perinatal depression
intervention on maternal and index child outcomes using a cluster randomized controlled trial (c-RCT) and (2) to
determine whether outcomes among index children of perinatally depressed women in the intervention arm converge
with those of index children born to perinatally nondepressed women. The trial is designed to recruit 560 pregnant
women who screened positive for perinatal depression (PHQ-9 score ≥10) from 40 village clusters, of which 20 receive
the THPP+ intervention. An additional reference group consists of 560 perinatally nondepressed women from the same
40 clusters as the THPP+ trial. The women in the nondepressed group are not targeted to receive the THPP+
intervention; but, by recruiting pregnant women from both intervention and control clusters, we are able to evaluate
any carryover effects of the THPP+ intervention on the women and their children. Perinatally depressed women in the
THPP+ intervention arm receive bimonthly group-based sessions. Primary outcomes are 3-year maternal depression
and 3-year child development indicators. Analyses are intention-to-treat and account for the clustered design.
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Discussion: This trial, together with the reference group, has the potential to further our understanding of the early
developmental lifecourse of children of both perinatally depressed and perinatally nondepressed women in rural
Pakistan and to determine whether intervening with women’s depression in the perinatal period can mitigate the
negative effects of maternal depression on 36-month child development.
Trial registration: THPP-P ClinicalTrials.gov Identifier: NCT02111915 (registered on 9 April 2014).
THPP+ ClinicalTrials.gov Identifier: NCT02658994 (registered on 21 January 2016).
Sponsor: Human Development Research Foundation (HDRF).
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development
Background
Perinatal maternal depression, defined by at least one
depressive episode during pregnancy and/or the first
postnatal year, has been shown to have negative
health effects for both the mother and the child.
Negative effects on the mother include reductions in
daily functioning as well as early mortality. Negative
effects on the child, including illness and poor
growth, start early and persist throughout the child’s
life [1–6]. Given that 10–35% of children worldwide
are exposed to perinatal depression in their first year
[7], mitigating this intergenerational risk is a global
public health priority [8–10]. Pakistan has one of the
highest rates of maternal depression globally, and one
of the only studies examining potential long-term
benefits of maternal depression interventions on child
outcomes found no significant effects [11].
The Thinking Health Program (THP), a community
health worker (CHW)-delivered intervention developed
and evaluated in Pakistan, was shown to have beneficial
effects on both perinatal maternal depression and short-
term child outcomes including reductions in diarrheal
episodes and increased vaccination rates [12]. In 2015,
the THP was formally designated by the World Health
Organization (WHO) as an evidence-based intervention
that could be implemented in a variety of global settings
using an established CHW healthcare delivery system
[13]. Unfortunately, many CHW systems, such as
Pakistan’s, are underfunded and stretched to capacity;
and alternative delivery methods are required. In re-
sponse to this need, the Thinking Health Program Peer-
delivered (THPP) was developed by adapting the THP to
be delivered primarily by peers who operate within the
existing CHW system. An ongoing study, the THPP-
Pakistan trial [14], seeks to evaluate THPP for 6 postna-
tal months.
Although effective in reducing maternal perinatal depres-
sion, our recent work failed to show that the 6-month
CHW-led THP led to improved longer-term child out-
comes [11]. At age 7 years, children of perinatally depressed
mothers who received the intervention did not show better
outcomes than children of control group mothers. To im-
prove the longer-term outcomes of both perinatally de-
pressed mothers and their children, we have developed the
Thinking Health Program Peer-delivered PLUS (THPP+),
an extension of the 6-month THPP intervention delivered
at a lower intensity for an additional 30 postnatal months
to the same women who have been receiving the THPP.
The THPP+ is an extension and a continuation of the
THPP intervention for mothers until the child is 3 years
old.
The aim of this manuscript is to describe the proto-
col for the THPP+ study in Pakistan. The THPP+
study is a cluster randomized controlled trial (c-RCT),
which compares outcomes among three groups of
mother-child dyads: (1) those receiving the interven-
tion, (2) those receiving Enhanced Usual Care (EUC)
in the control clusters, and (3) a reference group of
mother-child dyads in which the woman was not de-
pressed in pregnancy and resides in the same inter-
vention and control clusters where the trial is being
implemented. Focusing on outcomes at 36 postnatal
months, the goal of this c-RCT is to evaluate the cu-
mulative effectiveness of the combined THPP and
THPP+ interventions on mothers and their children.
The goal of the embedded reference group of peri-
natally nondepressed women and their children is
two-fold: (1) to evaluate whether the intervention is
able to meaningfully reduce the gap in child out-
comes that is traditionally observed when comparing
children of depressed and nondepressed mothers; and
(2) to determine whether there are any beneficial car-
ryover effects of the intervention on this nonde-
pressed group.
This manuscript complements and extends the THPP
trial protocol [14]. To ensure that the current protocol
is able to stand alone, we present the necessary key fea-
tures of the THPP design and the ways in which the
THPP+ trial builds on, and is different from, the on-
going THPP trial in Pakistan.
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Objectives and hypotheses
The primary objective of the study is to evaluate the im-
pact of a 36-month perinatal peer-delivered community-
based perinatal depression intervention on (1) maternal
depression and (2) child development. Our primary hy-
pothesis for the perinatally depressed mothers is that the
intervention will result in lower prevalence of depression
at 3 years postnatal. Our primary hypothesis for the chil-
dren is that the perinatal depression intervention will
lead to improved developmental outcomes (see “Mea-
sures and constructs” in Table 1) at 3 years of age. Add-
itional child hypotheses address proposed mediators and
moderators of the effects of the perinatal depression
intervention on child outcomes.
The second objective is to determine whether out-
comes of perinatally depressed mothers and children in
the intervention arm will converge to those in the refer-
ence group of perinatally nondepressed mothers and
children as well as, secondarily, to determine whether
there are any carryover effects of the intervention to
benefit perinatally nondepressed mothers and children.
Methods/design
Trial settings
The study will be conducted in rural Pakistan in the
rural Sub-District of Kallar Syedan, Rawalpindi, Pakistan.
Design
The THPP+ trial is a stratified cluster randomized con-
trolled trial (c-RCT) of 40 village clusters allocated in a 1:1
ratio to receive intervention or EUC within 11 strata de-
fined by Union Councils (sub-district units), each with an
even number of village clusters [15]. Cluster randomization
is used to avoid contamination between women since the
THPP intervention is delivered at the community level
through CHWs and peer women in the community. Strati-
fication is used to minimize imbalance in baseline
covariates.
THPP+ is conducted in the same 40 village clusters as
the THPP trial. The same study population of perinatally
depressed women is invited to consent to participate in
THPP+. An equal number of perinatally nondepressed
women are also recruited from each village cluster. The
latter forms the reference group that enables us to evalu-
ate whether convergence of maternal and child out-
comes occurs during the 3-year postnatal period. In
summary, all depressed women enrolled in the THPP+
trial were enrolled in THPP, while all nondepressed
women are only recruited to the THPP+ study. See Fig. 1
for details of the distinction.
In brief, the ongoing THPP trial focuses on the effects
of the THPP intervention on maternal outcomes at 6
postnatal months, with a limited number of child out-
comes measured. The THPP+ protocol is designed to re-
cruit the same 560 pregnant women who screen positive
for perinatal depression from the 40 village clusters de-
scribed above for the THPP trial, of which 20 clusters re-
ceive the THPP intervention delivered by trained lay
peer volunteers.
Participants and procedures
Figures 1 and 2 show recruitment and flow of both
the perinatally depressed and perinatally nondepressed
mother-child dyads through the study. After collecting
prebirth baseline information, we assess each mother
and her index child born during the study at 3, 6, 12,
24 and 36 postnatal months. The 3- and 6-month as-
sessments will coincide with those of the THPP trial.
The 12-, 24- and 36-month assessments are unique
to THPP+ (further details in Additional file 1).
Recruitment of study participants: inclusion and exclusion
criteria
The current THPP+ study consists of perinatally de-
pressed women and the index children who are partici-
pating in the THPP study and an additional sample of
nonperinatally depressed mothers and of the index child
Table 1 Primary outcome measures for women and children in the Thinking Health Program Peer-delivered PLUS (THPP+)
Source of data Postnatal months
Outcomes Measure 3 6 12 24 36
Mother: depression Patient Health Questionnaire (PHQ-9) ✓ ✓ ✓
WHO Disability Assessment Schedule (WHO-DAS) ✓ ✓ ✓
Child: socioemotional Total Difficulties score from the Strengths and Difficulties Questionnaire (SDQ-TD) ✓
Ages and Stages Questionnaire (ASQ) ✓ ✓ ✓ ✓
Child: developmental milestones Bayley Scales of Infant and Toddler Development III (BSITD-III) ✓ ✓ ✓
Child: physical Length, weight (WHO weight-for-length z-scores) ✓ ✓ ✓ ✓ ✓
Head circumference ✓ ✓ ✓ ✓ ✓
Diarrhea/ARI ✓ ✓ ✓ ✓
ARI acute respiratory infection, WHO World Health Organization
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of each mother. For THPP, pregnant women registered
with the CHW (called Lady Health Workers) were
approached. The study team has been engaged with the
Lady Health Workers and the community in the past and
enrollment rates have been consistently high. All eligible
women in their third trimester of pregnancy were assessed
for depression using the Patient Health Questionnaire
(PHQ-9) and those scoring above the 10-point cutoff were
invited to participate in the trial. For THPP, a random
sample of approximately a third of women scoring less
than 10 (i.e., screening negative on PHQ-9) are asked to
serve as an additional reference group of equal size as the
number of perinatally depressed women. In order to be
eligible to participate, women need to be married, to res-
ide in the study area, to understand one of the study lan-
guages (Urdu, Punjabi or Potohari), and to not require
immediate medical attention. Following a live birth, the
mother-infant dyads remain eligible to continue in the
study unless the woman develops a psychotic or manic
episode, or the dyad is broken through death, disability or
relocation of the woman or child. Any participant who de-
velops severe symptoms over the course of the study will
be immediately referred for additional treatment.
Informed consent
Women are informed about the study goals and study
design in the third trimester of pregnancy by trained re-
search staff. Those who agree to participate consent to
be followed up for 3 years postnatally and to participate
in an intervention if they screen positive for perinatal
depression. This consent covers the THPP+ period. The
additional THPP+ sessions are seamlessly added to the
existing intervention content for depressed women in
the intervention clusters.
Randomization
The current THPP+ study is designed to maintain the
randomization that was performed at the start of the
THPP. According to the randomization procedure, 11
UC strata were selected with an even number of village
clusters identified in each. Within each UC, village clus-
ters were then randomized in a 1:1 ratio. In total, there
are 20 intervention and 20 control arm clusters.
Interventions
Thinking Healthy Program Peer-delivered (THPP)
The Thinking Healthy Program Peer-delivered (THPP)
is an adaptation of the Lady Health Worker-delivered
THP, that was adopted by the WHO mhGAP Series [13].
The protocol for the THPP trial has been published [14].
Similar in content to the THP, the peer-delivered version
is simplified with additional strategies added for ease of
implementation by peers. The intervention focuses on
identifying and altering unhealthy behaviors with a focus
on behavioral activation to facilitate change. It consists
of both individual sessions with the peers as well as
Fig. 1 THPP+ study (both the trial of perinatally depressed mothers and the reference group of perinatally nondepressed mothers) in relation to
the THPP intervention trial showing anticipated loss to follow-up. N = number of mother-child dyads. Unshaded area is unique to the
THPP+ study
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group sessions held at the “Health House,” a room in
the home of the CHW dedicated for women’s group
meetings. The THPP begins in the third trimester of
pregnancy and finishes at the end of the sixth postnatal
month.
Thinking Healthy Program Peer-delivered PLUS (THPP+)
As part of THPP+, the intervention continues from the
beginning of the seventh postnatal month through the
end of the 36th month, and consists of an additional
30 months of lower-intensity services unique to the
THPP+ model. We use the term THPP+ to refer to the
combined 6-month THPP intervention and the 30-
month THPP+ intervention delivered consecutively
through 36 months after the index child’s birth. The
THPP+ includes group sessions to be held roughly every
other month for a total of 18 sessions over the interven-
tion duration. The content is a continuation of the pre-
vious THPP sessions with emphasis on self-care and on
the baby’s health and development. In order to ensure
continued participation, peers contact each woman a
week prior to the group session and the groups are held
in the community where the participants live and are
easily accessible. Peers keep session logs which are over-
seen by the peer supervisors and can be used for calcula-
tion of “dose” during analyses.
Fig. 2 Flow chart of the THPP+ study
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In case a woman misses attending a session the peer
follows up at the household to work out/negotiate with
the family to ensure attendance at the next session (so that
the “dose” is not missed).
Although the perinatally nondepressed women in the
intervention arm do not receive the THPP+ interven-
tion, by recruiting mothers from both intervention and
control clusters, we are able to evaluate any effects of
the THPP+ on the group that is not directly targeted.
Enhanced Usual Care
Women in the control clusters who were depressed pre-
natally have been receiving Enhanced Usual Care (EUC).
At the time of the screening (and with consent), women,
their Lady Health Workers and personnel in their local
primary health care facility were informed of the diagno-
sis; and women were given an information sheet about
depression and how to access care. There are no new
EUC protocols put in place postnatally as part of the
THPP+.
Additional training and supervision of peers
For the THPP, peers were trained in a 5-day classroom-
based workshop, followed by a 2-month internship dur-
ing which they practiced the content of the THPP on
nontrial participants [14]. For THPP+, peers will receive
an additional 2 days of classroom training after their last
session (during the fifth postnatal month) of the THPP
to cover the additional content. Competency is assessed
by role plays. Peer counselors continue to receive
monthly group supervision to maintain high motivation
and to address any challenges in the field.
Minimization of contamination
Risk of new contamination between the treatment and
control arms is expected to be very low given the low in-
tensity of the intervention and its placement after the
end of the more intensive intervention that began pre-
natally and lasted through to 6 postnatal months. The
cluster design makes it less likely that women will ex-
change information related to the intervention.
Masking of treatment allocation
Although it is not possible to blind study participants
from their treatment arm allocation, all project staff, in-
cluding interviewers, are blind both to a woman’s ori-
ginal depression status and to the treatment arm of the
village cluster in which she resides. Study participants
are instructed to not discuss their depression status or
intervention (or lack thereof ) with the assessors. The
data linking each village cluster with treatment alloca-
tion status is kept separate from the remaining outcome
dataset until the time of the final analysis.
Fidelity of the intervention
Fidelity of the intervention is assessed through docu-
menting the number of women who attend the meetings
in combination with documenting the content covered
during the meetings and the duration of each compo-
nent covered in the session.
Data management
All data capture is performed electronically on tablets
and uploaded daily to the main server. Quality checks
for consistency, accuracy, missing data and other irregu-
larities are conducted weekly. Any issues are shared with
the research team and discussed during a weekly staff
meeting to address source of any problems in the field.
Data are backed up daily. Data are deidentified/anon-
ymized before being shared with coinvestigators outside
of the Human Development Research Foundation
(HDRF). At all stages, data are password-protected with
multiple layers of authorization.
Outcome evaluation
The primary endpoint is designed to be at 3 years post-
natally. The primary comparison tested is between peri-
natally depressed-intervention versus perinatally
depressed-control women in order to evaluate the effect-
iveness of the THPP+ intervention on long-term out-
comes in perinatally depressed mothers and their
children born during the intervention period (i.e., “index
child”). Secondary comparisons for mothers and their
index children are (1) intervention perinatally depressed
mothers versus control perinatally nondepressed
mothers to assess convergence of outcomes in both
mothers and children and (2) intervention perinatally
nondepressed versus control perinatally nondepressed
mothers to assess whether there are any carryover effects
of the intervention that benefit perinatally nondepressed
mothers and their index children. For the former, the
statistical goal is to demonstrate equivalence of out-
comes of control perinatally nondepressed and interven-
tion perinatally depressed mothers and their children.
For the latter, the goal is to test the null hypothesis of
no difference between groups in the outcomes of inter-
est. The mother and child outcome measures are de-
tailed in Tables 1 and 2.
Mother outcome measure
Patient Health Questionnaire (PHQ-9)
The PHQ-9 is the main indicator of depression symp-
toms among the women in the study. The PHQ-9 in-
quires about frequency of depressive symptoms in the
last 2 weeks. It has been validated and used extensively
in the region [16, 17].
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WHO Disability Assessment Schedule (WHO-DAS)
The WHO-DAS is a 12-item questionnaire assessing
levels of function over the last 30 days. Combined with
two items about one’s ability to work in the last 30 days,
the WHO-DAS generates a total disability score, quality-
adjusted life years and number of days the respondent is
not able to work [18].
Child outcome measures
Socioemotional development
Our main outcome measure is the Total Difficulties
(TD) score derived from the Strengths and Difficulties
Questionnaire (SDQ). The SDQ is a parent report of 25
child attributes divided into five subscales: emotional
symptoms, conduct problems, hyperactivity, peer prob-
lems and prosocial behavior [19]. The TD score is calcu-
lated based on four subscales (except prosocial behavior)
with a score range of 0–40 points [20]. The SDQ has
previously been translated into Urdu as well as at least
50 other languages and used in low- and middle-income
countries [21–23].
ASQ
Socioemotional developmental milestones, prior to and in-
cluding 36 months, are assessed with the Ages and Stages
Questionnaire Socio-Emotional scale (ASQ-SE) [24, 25].
The ASQ is a widely used, simple set of 25 questions where
parents are asked to report age-appropriate milestones
with the help of simple examiner-administered examples,
such as whether, at 8 months, the child plays with a toy by
banging it up or down on the floor or table [26].
Infant developmental milestone achievement
Bayley Scales of Infant Development The Bayley
Scales of Infant and Toddler Development, Third Edi-
tion (BSID-III) is an individually administered assess-
ment of the child’s achievement of developmental
milestones across five areas: cognitive, language, motor,
social-emotional and adaptive skills [27]. The evaluations
are conducted in the family’s home at infant ages 12, 24
and 36 months. Raw scores in each domain are summa-
rized by chronological age-related scaled scores and
composite scores for each domain. The standard scores
are derived from the US norms; and, because there are
no available Pakistani norms, the scores provide a metric
with which to compare groups of children in this
Pakistan setting relative to the study hypotheses. The
evaluators were trained in administration of the BSID-III
by the team clinical psychologist (O’Donnell, US-based)
and by the local team, which includes a psychiatrist and
a physician. Periodic quality assurance is assessed at
least quarterly by dyadic testing (evaluator plus team
psychologist) and by double scoring by the US-based
psychologist.
Physical development
Physical development is assessed using weight-for-age
and height-for-age. Weight-for-age is sensitive to weight
change over a short time period but fails to distinguish
Table 2 Outcome assessments
Instrument Description Outcome Contextual validity
PHQ-9 Nine-item questionnaire assessment of
depressive symptoms assessed on a scale of 0
to 3
Prevalence of moderate–severe
depression; mean total score
Validated in primary care [37]
WHO-DAS 12-item questionnaire for measuring
functional impairment over the last 30 days. In
addition, two items assess the number of days
the person was unable to work in these
30 days
Total disability score; quality-adjusted
life years; number of days out of work
Validated for international use [18]
SDQ-TD The SDQ is a parent report of 25 child
attributes divided into five subscales:
emotional symptoms, conduct problems,
hyperactivity, peer problems and prosocial
behavior
Total Difficulties score: calculated based
on four subscales (except prosocial
behavior)
The SDQ has previously been translated into
Urdu as well as at least 50 other languages
and used in low- and middle-income countries
[21–23]
ASQ The ASQ is a widely used, simple set of 30
questions appropriate for 4–60 month-olds
that assesses five domains of development
The total score from the five domains,
plus the score from an additional
domain on the child’s socioemotional
development
The parent-report-based ASQ assessments
have been shown to have good concurrent
validity with professionally administered BSITD
[24, 38], including internationally [39, 40]
BSITD-III An individually administered assessment of
the child’s achievement of developmental
milestones across five areas: cognitive,
language, motor, social-emotional and adaptive
skills [27]
The total score from each domain The standard scores are derived from the US
norms; and, because there are no available
Pakistani norms, the scores provide a metric
with which to compare groups of children in
this Pakistan setting relative to the study
hypotheses
ASQ Ages and Stages Questionnaire Socio-Emotional scale, BSITD-III Bayley Scales of Infant and Toddler Development, Third Edition, PHQ Patient Health
Questionnaire, SDQ-TD Strengths and Difficulties Questionnaire, WHO-DAS WHO Disability Assessment Schedule
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tall, thin children from those who are short with ad-
equate weight. Height-for-age is useful for identifying
children with short stature, a group often vulnerable to
longer-term adverse conditions. Based on WHO norms,
a measure of 2 standard deviations (SD) below the mean
of either weight or height is chosen to indicate poor
growth. Head circumference is measured through
24 months. Physical health indicators are recent diar-
rheal episodes and acute respiratory infections.
Power calculations
The primary power calculations for the THPP+ study
are for the c-RCT comparisons of perinatally depressed
women and their children in the control versus interven-
tion arms at 36 postnatal months at the 5% two-tailed
significance level. As for the THPP trial [14] we assume
40 village clusters randomized in a 1:1 allocation ratio
within 11 UCs, with 14 perinatally depressed women per
village cluster, to yield a total sample size of 560 peri-
natally depressed women at baseline. In addition, for
THPP+ we recruit 14 perinatally nondepressed women
per village cluster for a total of 560 perinatally nonde-
pressed women at baseline. We conservatively estimate
that loss to follow-up (including infant mortality and
maternal illness and death) of both perinatally depressed
and perinatally nondepressed women at 36 months will
be 20% (anticipated loss to follow-up in the THP trial
was 10% at 6 months and most loss to follow-up is ex-
pected in the first 6 months of the study) [12]. There-
fore, the total sample size available at 36 months is
anticipated to be 480 perinatally depressed and 480 peri-
natally nondepressed women and their children. Using a
standard formula [28, 29] for a cluster randomized de-
sign and assuming an intracluster correlation of 0.07 in
the intervention arm and 0.05 in the control arm, the
trial will have 90% power at 36 months to detect a dif-
ference in perinatally depressed remission of 65% in the
perinatally depressed-intervention versus 45% in the
perinatally depressed-control for the anticipated total
sample size of 480 perinatally depressed women at
36 months. For child outcomes, this sample size will yield
power of more than 90% to detect a difference between
arms in mean TD score (range 0–40) of 3 points for chil-
dren of perinatally depressed mothers using plausible esti-
mates for intracluster correlations of 0.04–0.08 [12], and
5.2 for SD for the TD score among 3 year-olds [30].
Secondary comparisons mainly focus on child out-
comes and are well-powered. For the secondary hypoth-
esis of equivalence between children of perinatally
depressed mothers in the intervention arm and peri-
natally nondepressed mothers in the control arm, we
will conclude equivalence if the 95% confidence interval
(CI) for the difference between the mean score in the
two groups lies between −2 and 2 units. We note that
differences of 1.0–2.0 points are often observed between
boys and girls [30, 31]. With 220 children in each group
and conservatively assuming an overall significance level
of 2.5% (corresponding to the 95% CI), an SD of 5.2
and an ICC of 0.04, and no difference between the
groups, we will have 83% power to conclude equiva-
lence [28, 32]. For the secondary research question of
the community benefit (i.e., carryover) of the interven-
tion for perinatally nondepressed women and their chil-
dren, we will have 80% power to detect a 1.7 or greater
impact of the intervention on mean TD score (groups:
perinatally nondepressed-intervention versus perinatally
nondepressed-control, Fig. 1) for the same assumptions of
the primary comparison above.
Analysis
Statistical analysis will be conducted according to the
Consolidated Standards of Reporting Trials (CONSORT)
guidelines. A flow chart will show participation of both
perinatally depressed and perinatally nondepressed
mothers and their children from recruitment in the third
trimester through to 36 postnatal months (Fig. 2). With-
drawals and loss to follow-up will be shown at each
follow-up (3, 6, 12, 24 and 36 postnatal months). Base-
line characteristics of recruited mothers will be reported
by study arm, and separately for perinatally depressed
and perinatally nondepressed mothers. Continuous vari-
ables will be summarized by means and standard devi-
ation (SD), or medians and the 25th and 75th percentile,
if needed. Categorical variables will be summarized by
counts and percentages.
The primary analyses are designed as intention-to-
treat and will be conducted using the latest release of
Stata software. Separate outcome analysis will be con-
ducted for mothers and for children. In both cases, data
from perinatally depressed and perinatally nondepressed
participants will be analyzed jointly using generalized
linear mixed-effects models so that all comparisons of
interest can be estimated from the same model. The
identity link will be used for continuous outcomes in
order to estimate differences in mean outcomes. The
log-link will be used for binary outcomes in order to es-
timate prevalence ratios, but if convergence is not
achieved we will use the logit link from which preva-
lence ratios will be estimated. Random intercepts for
cluster will be included to account for the clustered
study design. For outcomes measured at multiple follow-
up time points (e.g., for depression status in both peri-
natally depressed and perinatally nondepressed mothers,
which will be evaluated at all five follow-up time points),
random intercepts for person will be added to account
for correlation of repeated measures on person. Simi-
larly, in this case, random slopes for both cluster and
participant will be considered to allow for heterogeneity
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by cluster and participant over time. All random error
terms will be assumed independent and zero-mean nor-
mally distributed.
Primary analyses of outcomes measured at a single
follow-up time point are designed to include the follow-
ing fixed-factor variables: arm (intervention versus con-
trol), strata (11 Union Councils), baseline depression
status (perinatally depressed versus perinatally nonde-
pressed) and its interaction with arm. For outcomes
measured at multiple follow-up time points, the interac-
tions between study arm, follow-up time point and base-
line depression status will be included to allow for
different intervention effects at each follow-up time
point. Estimates of the prespecified comparisons of
interest will be derived from the fitted model. Conclu-
sions about the equivalence of perinatally depressed-
intervention and perinatally nondepressed-control will
be based on whether the corresponding 95% CI is con-
tained within the equivalence margins (i.e., −2 to 2 for
the primary child outcome of the TD score). Model as-
sumptions will be assessed; in the case of non-normally
distributed residuals, we will consider bootstrapping or
transformations to obtain valid CIs.
Secondary analyses will include any baseline covariates
for which there was chance baseline imbalance and for
any additional baseline covariates that predict missing
outcome data. Under the assumption that those covari-
ates explain the missing data mechanism, we will obtain
valid estimates of the intervention effects using the
complete case data (i.e., without the need for imputation
or an alternative method) [33]. If there are concerns or
evidence that covariates cannot explain the nature of the
missingness (i.e., if the data are missing not at random),
we will perform a series of sensitivity analyses based on
the pattern mixture approach [34].
Moderator and mediator analyses
In addition to our main outcomes, auxiliary analyses
focus on potential moderators and mediators of any
main associations. A-priori variables that might impact
the degree to which the intervention affects depression
symptoms include socioeconomic status, household
composition, and the presence of interpersonal violence.
These associations will be examined by including an
interaction between the variable of interest and the
intervention indicator in the primary outcome model.
Potential mediators of interest include maternal respon-
siveness, the mother-child relationship and social
support.
Compliance analysis
We plan to gather information on compliance with the
intervention and evaluate whether there is any evidence
of contamination between treatment arms.
Trial management
Trial monitoring procedures are a continuation of pro-
cedures and infrastructure in place for the THPP. This
includes oversight by two committees: the Trial Manage-
ment Committee (TMC), which is charged with close
monitoring of all aspects of the trial and its progress and
the Trial Steering Committee (TSC), which will provide
additional guidance on the overall trial protocols as well
as oversee trial safety issues. The TMC is composed of
the principal investigators and the site team (project dir-
ector, data manager/trial manager, local outcome assess-
ment trainer); it meets weekly. The TSC is composed of
the principal investigators, study coinvestigators, the trial
manager and the study statistician; the TSC will meet
every 6 months.
Ethical considerations
We protect the confidentiality of personal data princi-
pally through procedures to separate study data and par-
ticipant identifiable data. Quantitative data gathered
with the tablets for each participant at baseline retain
personal identification items to minimize errors in tran-
scribing identities, but these will be removed before
transferring the data to Stata for analysis. We monitor
the occurrence of a number of specific serious adverse
events (SAEs) beyond the THPP trial (among the de-
pressed cases); these include death of the participant or
her child due to any cause, suicide attempt, hospital ad-
mission due to a psychiatric problem, and hospital ad-
mission of participant or infant due to a serious medical
emergency. Their detection and appropriate response
(involving an independent psychiatrist responding) will
be reported to the local Ethics Committee. These SAEs
are compiled by the data manager and a blinded sum-
mary report is shared with the principal investigators
and the TSC.
Discussion
This trial and the parallel reference group of perinatally
nondepressed women have the potential to further our
understanding of the early developmental lifecourse of
children of both women who were, and were not, peri-
natally depressed and to evaluate whether intervening on
mothers’ perinatal depression can mitigate the negative ef-
fects of maternal depression on child development at
36 months. By beginning our study in the third trimester
of pregnancy and following the mother-child dyads with
multiple assessments through 36 postnatal months we will
be able to analyze the relationship between changes in
maternal depressive symptoms and child outcomes. For
example, we will be able to analyze the impact of early ver-
sus late remission; remission of symptoms followed by re-
currence; and new onset of symptoms on child outcomes.
With the 3 years of follow-up with multiple assessments,
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we will be able to undertake an analysis of potential time-
varying mechanisms.
By also enrolling a group of women who were peri-
natally nondepressed we are additionally be able to ad-
dress two substantive questions. The first is: How much
of the risk due to maternal depression exposure can the
intervention mitigate? We ultimately want to know
whether the intervention can prevent the intergenera-
tional transmission of negative mental health outcomes.
The children of prenatally depressed mothers in both
intervention and control arms of the THPP+ interven-
tion study are at high risk for multiple adverse out-
comes. We expect that, at the end of the study, the
children in the intervention arm will be at lower risk.
However, the full impact of the intervention can only be
discerned if we know the level of risk remaining – that
is, the difference between the reduced level of risk
among children (of prenatally depressed mothers) in the
intervention arm and the risk among children whose
mothers were not depressed to begin with. If outcomes
of these two groups are comparable, we can infer that
the intervention may prevent the intergenerational
transmission of risk. Unlike in high-income country set-
tings, normative data for such a comparison does not
exist in many low-resource areas, including Pakistan;
hence, the enrollment of nondepressed women [35, 36].
The second substantive question is: Does the interven-
tion have an impact on mothers and children living in
the intervention clusters, even if the mother was not de-
pressed prenatally? The community intervention was
originally designed to improve outcomes among de-
pressed women. However, we suspect that its design
may lead to broader, population-wide effects.
By working in a rural setting in Pakistan and by
combining the cohorts of perinatally depressed
mothers in the c-RCT and nonperinatally depressed
mothers, the THPP+ study offers a unique opportun-
ity to understand, and to potentially help to mitigate,
the effects of perinatal depression on both the mother
and the child.
Trial status
The THPP trial (and hence the THPP+ trial) began re-
cruitment of participants in October 2014. Based on our
previous work and pilot results with an approximately
25% rate of perinatal depression, we expect to recruit
the sample by the end of February 2016. The endpoint
assessments of all the participants at 36 postnatal
months will be completed by end 2018.
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